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ABSTRACT
VIRAL AND IMMUNE STUDIES ON BOVINE VIRAL DIARRHEA VIRUS (BVDV)
IN BOVINE SPECIES
KARIM ABDELSALAM
2021
BVDV is a major pathogen of ruminants that causes immune dysfunction and
lead to secondary bacterial infection. The underlying mechanism of this dysfunction is
not well understood. Based on previous results, we believe that macrophages play a
central role in BVDV-associated immune dysfunction. Previously, we have shown that
the infected monocyte-derived macrophage (MDM) supernatant of the high virulent
strains of BVDV significantly induced lymphocyte apoptosis. In the current study, we
performed experiments to identify the apoptotic factors in the infected MDM
supernatants in vitro. Also, we have extended our investigation to include testing the
impact of infected macrophages on neutrophil viability, surface marker expression, and
functional activity.
The infected-MDM supernatants did not impact neutrophil viability. The
supernatants did down-regulate CD18 and significantly down regulated L-selectin
expression. Interestingly the supernatants had no significant effect on neutrophil
phagocytic activity nor oxidative burst. Only cytopathic BVDV-infected supernatant
significantly down-regulated nitric oxide production and neutrophil extracellular traps
(NET) induction in pre-stimulated cells. Viral-protein-depleted-MDM supernatants were
still capable of inducing lymphocyte apoptosis. Tumor necrosis factor-alpha and
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interleukin-1-beta, two apoptosis-related cytokines, were not detected in the virulent
supernatant. Our data suggested an important role of macrophages in the mechanism of
immune dysfunction that affects neutrophil function and induced lymphocyte apoptosis.
Unlike lymphocyte apoptosis that depends on the highly virulent BVDV, the negative
impact on neutrophil functional activity seems to be biotype specific, especially the
BVDV cytopathic (Cp) biotype that is the biotype in most of the commercially available
vaccine in the US. Our data also suggested that neither viral proteins nor two proinflammatory cytokines are involved in inducing lymphocyte apoptosis. However further
testing is required to identify these immune-dysfunction-related factors.
The second part of the dissertation included both an in vivo investigation of bison
viral infections and an in vitro study on susceptibility of a primary cell line to 4 viruses
associated with bovine respiratory disease. The in vivo study observed the tropism and
co-infection of BVDV and Bosavirus, a novel Copiparvo virus, in different tissues of the
American bison. The in vitro study focused on comparing the viral susceptibility and
immune response of a primary bovine tracheal cells and the established BT cell line to
BRD-related viral pathogen. We found that the co-infection of both viruses negatively
impacts the replicative ability of each other in different tissues on the viral nucleic acid
level. The viral load of BVDV in the skin of persistently infected (PI) cattle is higher than
that of the American bison. Skin ear notches are the gold standard used for detecting
BVDV PI cattle, however this finding may indicate for bison other samples besides ear
notch-skin samples may be better for PI diagnostics depending the viral load in the
tissues. The in vitro cell culture study found that we can rely on biologically relevant
primary bovine tracheal cells in studying BVDV and BHV-1 the primary cells had

xv

similar susceptibility, growth kinetics and IFN-I response to that of the established
bovine turbinate (BT) cell line
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CHAPTER 1
RESEARCH OBJECTIVES AND LITERATURE REVIEW
INTRODUCTION
Bovine viral diarrhea virus (BVDV) is an endemic viral disease of cattle in the
US. While cattle are the main reservoir, BVDV can infect a wide range of other
ruminants, including American bison, and can invade and replicate in many tissues.
BVDV is known for its immune-suppressive effect on the infected animal, and for its
ability to persistently infect bovine species, creating a persistently infected (PI) animal.
Immune suppression is usually associated in the field with lymphoid depletion in the
infected animal and is usually followed by a secondary bacterial infection. while PI
animal is the main source of infection that continues to spread the infection on the farm.
This will subsequently lead to the failure of the current control strategies and increase the
prevalence rate of BVDV among cattle farms. The overall goal of this research was to
reveal the macrophage-mediated immune dysfunction in infected animals with virulent
strains of BVDV. Since secondary bacterial infection is a common sequel following
BVDV infection, it is important to study the impact of this macrophage-mediated
dysfunction on neutrophils as the main cells associated with a bacterial infection. Our
preliminary results showed that the infected macrophage with virulent strains of BVDV
leads to the secretion of soluble factors that induced apoptosis in the total lymphocyte
population.
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In this study our research objectives were: 1) Identify the soluble factors of the infected
macrophage that induce lymphocyte apoptosis. 2) Examine the effect of these soluble
factors on the functional activity of neutrophils to investigate a possible immune cell
interaction in response to BVDV infection. 3) Investigate the trophism of BVDV in
different tissue of the American Bison and its co-existence with Bosavirus. 4) Examine
the susceptibility of a new primary cell line to BVDV and other BRD-related pathogens.
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LITERATURE REVIEW

1. Bovine Viral Diarrhea Virus (BVDV)
Bovine Viral Diarrhea Virus (BVDV) is a small enveloped, positive-sense singlestranded RNA virus that belongs to the genus, Pestivirus and the family, Flaviviridae.
BVDV includes 2 genotypes: BVDV 1 and 2, and 2 biotypes; cytopathogenic (Cp) and
non-cytopathogenic (Ncp), according to the ability to the virus to induce a cytopathic
effect (CPE) on cell culture. It has a 12.5 kb viral RNA genome that encodes a single
polyprotein that is processed by the combination of viral and host proteases to generate
four structural proteins (Capsid, Erns, E1, and E2) and seven non-structural proteins
(Npro, p7, NS2-3, NS4A-B, and NS5A-B) (Figure 1.1) (Neill, 2013). Two of the
proteins, Npro and Erns, can be secreted in the infected culture supernatant and were
inhibit Type 1 interferon (IFN) responses by degrading the viral RNA and interferon
regulatory factor-3 (IRF-3), respectively (Meyers et al., 2007; Tao et al., 2017). BVDV is
a pantropic virus that uses CD46 receptors that are abundantly expressed in most bovine
nucleated cells that allow the virus to infect different body systems and cause respiratory,
digestive, reproductive, and immune suppressive problems in the infected herds (Hafez,
1975; Ridpath et al., 2006; Merwaiss et al., 2019). The main concerns with BVDV
infection are the production of persistently infected animal (PI) and the condition of
immune dysfunction that follow either the PI or transiently infected animals. PI animals
are the main source of BVDV spread worldwide where it is uncurable and hard to be
early detected in the farm (Chernick et al., 2018; Fulton, 2013). Immune dysfunction is a
unique feature of BVDV infection that leads to secondary bacterial infection and
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increases the risk of vaccination failure in the infected herd (Ackermann et al., 2010;
Ridpath et al., 2006). This will lead to the continual spread of the virus and a high
prevalence rate. The virus' high prevalence rate, resultant abortions, persistent infections
(PI), and manifestations (i.e., mucosal disease) make prevention and active management
of BVDV essential for cattle producers (Ridpath, 2013). Also, BVDV is a part of the
bovine respiratory disease complex (Hay et al. 2016) that lead to severe annual economic
losses in the cattle industry (Givens and Newcomer, 2015; Johnson and Pendell, 2017;
Driskell and Ridpath, 2006).
2. BVDV Immune Response
2.1. Immunology to natural infection
Infection of normal calves with bovine virus diarrhea virus (BVDV) is a transient
self-limiting infection that can result in a period of immunosuppression (Howard, 1990).
Both humoral and cellular immune responses following natural infection are protective.
Much of the B cell response (as measured by serum antibodies) is directed against the
viral proteins E2 and NS2/3, with minor responses against the Erns and E1 proteins. The
major neutralizing epitopes are conformational and are located within the N-terminal half
of the E2 protein (Ridpath, 2013). E2 induces neutralizing antibodies in experimental and
natural hosts. Moreover, neutralizing antibodies raised against E2 can protect susceptible
hosts from infection with BVDV (Ferrer et al., 2007; Rosas et al., 2007; Thomas et al.,
2009). The induced antibodies against BVDV result in a 4-fold rise 2-4 weeks postinfection. The response is detected at a peak 8 to 10 weeks up to 1 year after infection
then the antibody levels decrease very slowly (Howard, 1990). The heterogeneity that
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exists among circulating BVDV strains prevents protective cross-immunity (Ridpath,
2013).
2.2. Immunology to vaccinated animals
Both modified live and killed vaccines are efficacious under controlled
conditions. Both humoral and cellular immune responses are protective. Following
natural infection or vaccination with a modified live vaccine, most of the B cell response,
as measured by serum antibodies, is directed against the viral proteins E2 and NS2/3,
with minor responses against the Erns and E1 proteins. Thus, E2 glycoprotein constitutes
an excellent candidate for the development of an experimental subunit vaccine.
Vaccination with killed vaccines results in serum antibodies directed mainly at the E2
protein. Vaccination, while not 100% effective in every individual animal, is effective at
the herd level (Ridpath, 2013).
2.3. Immunology of PI animal
PI animals develop neither neutralizing nor non-neutralizing antibodies against
BVDV, due to specific B and T lymphocytes immunotolerance (Larsson and Fossum,
1992). Sometimes, PI animals develop low titers of antibodies that continue to decrease
with time. The presence or absence of neutralizing antibodies in PI animals is probably
based on the stage of pregnancy and the involvement of maternal previously present
maternal antibodies (Kane et al., 2015). However, it is considered immunocompetent
against other viruses (Houe and Heron, 1993). Passively derived BVDV antibodies
decrease more rapidly in PI calves than in immunocompetent. The BVDV
immunotolerance is highly specific: immunotolerant animals, upon infection with a
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sufficiently different type of BVD virus, develop an immune response against that virus
without, however, being protected against their "own" virus, i.e., the immune system can
differentiate between sufficiently distinct types of viruses (Chase et al., 2004). BVDV
uses the macrophage/dendritic cell as a 'lymphocyte hitman' that will help with
lymphocyte apoptosis (Chase et al., 2015).
3. BVDV and immune dysfunction
Immune dysfunction is the inability of the immune system to function properly
towards different invading pathogens. BVDV is the major cattle health problem despite
the current control strategies and all efforts to decrease its incidence. The immune
dysfunction associated with BVDV is believed to be a consequence of lymphoid
depletion that can be mild or severe based on the virulence of BVDV strains (Ammari et
al., 2012; Falkenberg et al., 2014; Liebler-Tenorio et al., 2003). The exact mechanism by
which virulent BVDV strains exert their immunosuppressive effect is not well
understood. Several studies suggest the possible role of macrophages in lymphoid
depletion and immune dysfunction associated with BVDV. Furthermore, BVDV induces
multiple abnormalities to immune cell function and immune mediators that could
potentiate viral infection and pathogenesis. (Potgieter, 1995; Sopp, et al., 1994).
The pattern recognition receptors (PRR) include Toll-like receptors (TLR),
retinoic acid-inducible gene-I-like receptors (RIG-I-like receptor) and nucleotide-binding
oligomerization domain-like receptors (NOD-like receptors) play an important role in the
innate immune system. These receptors activate the innate immune system and shape an
effective adaptive immune response (Kawai and Akira 2009, Kumar et al. 2011). The
interaction of TLR with their respective ligands leads to downstream pathway changes to
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cytokines and chemokines (Schaefer et al. 2004). More virulent NCP strains enhance proinflammatory cytokines (Chase, personal communication). Ncp BVDV did not induce
type 1 interferons in vitro (Diderholm and Dinter 1966). However, a strong type 1
interferon response was observed in an in vivo experiment with a similar ncp strain,
indicating that BVDV biotypes behave differently in various environments (Charleston et
al. 2002). Ncp BVDV infection reduced IFNγ and IL-12 production (Risalde et al. 2011).
IL-12 acts as a growth factor for NK cells and cytotoxic T cells (Trinchieri 1995),
indicating that BVDV infection can indirectly affect NK cells and T cells activity through
IL-12. In addition to cytokines, various antimicrobial peptides and superoxides also
modulate the innate immune response (Ganz 2003, Break et al. 2012). Both Cp TGAC
and Ncp TGAN BVDV reduced phorbol-12-myristate-13 acetate (PMA)-induced
superoxide production following infection, while only Ncp BVDV primed bone marrowderived macrophages (BMDM) enhanced reactive nitrogen production in response to
Salmonella Dublin (Adler et al. 1994). Similarly, only BVDV2, not BVDV1 inhibited the
LPS-induced upregulation of tracheal antimicrobial peptide (TAP) mRNA (Al-Haddawi
et al. 2007). Another study showed that BVDV (unidentified strain) inhibited
phytohemagglutinin- (PHA), PHA plus phorbol-12-myristate-13 acetate- (PMA) or PHA
plus calcium ionophore (A23187)-stimulated bovine peripheral blood mononuclear cell
(PBMC) proliferation. Further, BVDV inhibited A23187stimulated leukotriene
B4(LTB4) synthesis in the culture supernatants (Atluru et al. 1992).
Previous studies outlined the impact of BVDV on both, the innate and the
adaptive immune response (Peterhans et al., 2003; Chase et al., 2004; Peterhans et al.,
2013; Chase, 2013; Chase et al., 2015). It was reported several times that the complicated
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cases of BVDV are associated with severe lymphoid depletion in the lymph nodes and
spleen (Ridpath et al., 2006) Interestingly, this lymphoid depletion was associated with
an increased number of macrophages 3 days post-infection in lymphoid tissues (Pedrera
et al., 2009). The presence of this significant number of macrophages in the lymphoid
tissues suggests an indirect effect of this cell on the lymphoid depletion caused by
BVDV. Although only cytopathogenic (CP) strains can induce direct apoptosis to
peripheral blood mononuclear cells (PBMCs) (Zhang et al., 1996, Lambot et al., 1998),
the most severe BVDV immune dysfunction is caused by virulent non-cytopathogenic
(NCP) strains, that we used in our preliminary research, and is associated with severe
lymphoid depletion (Falkenberg et al., 2014).
Infection of bone marrow hematopoietic cells by classical swine fever virus
(CSFV), a member of the same virus family, does not induce apoptosis in most infected
cells but does cause apoptosis in the uninfected cells suggesting an apoptotic role for
soluble factors released from infected cells (Schweizer and Peterhans, 1999 and 2001).
Candidate factors that could induce such apoptosis could be cytokines. The role of
apoptosis-related cytokines, like tumor necrosis factor-alpha (TNF-a), has been reported
to be a key determinant in the lymphocyte apoptosis process induced by CSFV (Pedrera
et al., 2009). It has also been hypothesized that the pestivirus-specific Erns glycoprotein
could be secreted and play a role in the apoptosis mechanism associated with CSFV
(Bruschke et al., 1997; Fetzer et al., 2005). It was also reported that CSFV (Summerfield
et al., 2001), and Cp BVDV (Adler et al., 1997) prime uninfected cells for activationinduced apoptosis. The mechanism for activation-induced apoptosis is virus-specific.
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Pregnancy-associated glycoprotein 1 (PAG 1), as well as miRNA and proteins
containing exosomes, has shown a significantly different profile between the infected and
non-infected pregnant sheep with BVDV (Lear., 2019). A recent publication showed the
different distribution of tRNA halves in the infected group with Ncp BVDV compared to
the control group (Taxis et al., 2019). Long non-coding RNA has also been involved in
the immune response following NADL-BVDV infection (Ma et al., 2017). This is in
addition to several miRNA candidates that have been involved with BVDV infection
(Taxis et al., 2017). These candidates could be part of the soluble factors that induced
macrophage-mediated lymphocyte apoptosis.
3.1. BVDV-macrophage interaction
Bovine macrophages are an important innate phagocytic cell as well as antigenpresenting cell. These cells are responsible for the uptake of infectious agents both to
eliminate pathogens and process the antigen for the effector immune cells to exert their
specific immune mechanism to clear the infection. Macrophages originate from
hematopoietic stem cells and myeloid progenitor cells present in the bone marrow.
Monocytes, the progenitor for macrophages develop from myeloid stem cells in the bone
marrow. The monocytes traffic from into the tissues to differentiate into professional
macrophages (Chase et al., 2015). The number of macrophages as well as dendritic cells
increased in lymphoid tissue 3 days post-infection. This increase may be the result of
antigen-presenting role, cell debris phagocytosis role, or indirect apoptotic role of
macrophages especially since their presence was associated with severe lymphoid
depletion (Ridpath et al., 2006). Macrophages are an important innate immune cell in the
pathogenesis of BVDV. Unlike monocyte, macrophages failed to produce BVDV new
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progeny after infection however the virus that can replicate and synthesize its viral
proteins (Chase et al., 2015). BVDV infection doesn't affect the viability of MDM in
vitro (Chase et al., 2004; Rajput et al., 2014). Interestingly, the macrophages and
dendritic cells surrounding the apoptotic lymphocytes in the lymphoid tissue don't seem
to be infected with BVDV (Liebleret al., 2003). In vitro infection of cultured
macrophages with BVDV was associated with an increased level of IL-1 and IL-6 but not
TNF- α (Peterhans et al., 2003). Macrophages infected with the Cp strain of BVDV
produced factors that included IFN-beta that triggered LPS-induced apoptosis.
Considering that the principal lesions of mucosal disease, the lethal form in PI animals
following co-infection with cytopathic BVDV, are in regions with high concentrations of
endotoxin (the oral cavity and gastrointestinal tract), that may suggest pathogenesis for
mucosal disease (Adler et al., 2021).
The immune dysfunction effect of BVDV targets macrophages and monocytes. In
bovine monocytes, Ncp BVDV infection suppressed gene expression of proinflammatory cytokines TNF-α, IL1-β, and IL6 and co-stimulatory molecules CD80 and
CD86 (Lee et al., 2008). Infection with BVDV stimulates the production of PGE2 in
bovine macrophages (Van Reeth and Adair, 1997) and inhibits the synthesis of
leukotriene B4 in bovine mononuclear cells (Atluru et al., 1992). The level of suppression
of the adaptive immune response is strain dependent. Non-cytopathic (Ncp) BVDV
infection stimulates cytokines from macrophages that will lead to decreased antigen
presentation capacity, and co-stimulatory molecules are downregulated (chase et al.,
2013). The BVDV-infected monocytes reduced leukotriene B4, an important mediator to
produce some proinflammatory cytokines as IL-1, IL-2, and IFN-alpha (Atluru et al.,
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1992). Infection with both Cp and Ncp BVDV compromised antigen uptake in bovine
monocytes (Boyd et al., 2004). Monocytes infected with Ncp BVDV were compromised
in their ability to stimulate T cell responses (Glew et al., 2003). Unlike Ncp strains, Cp
BVDV up-regulates both IFN type I and IL-12 within 1 h post-infection of monocyte.
The expressions of MHC class II were markedly decreased in Ncp BVDV2-infected
monocytes compared with the Ncp BVDV1-infected cells. Furthermore, interferon
gamma (IFN) production was significantly decreased in Ncp BVDV2-infected monocytes
compared to those with Ncp BVDV1 infection. That suggests that Ncp BVDV2 causes
reduced expressions of MHC class II and a decreased production of IFN, resulting in
evasion of immune recognition and suppression of the antiviral defense mechanism of the
innate immune response. Consequently, the results demonstrate that Ncp BVDV1 and
Ncp BVDV2 interact differently with the host's innate immune response and provide
insight into the mechanism by which Ncp BVDV2 impairs antigen presentation, fails to
control the viral infection and causes more severe disease (Choi, K. S., 2017). Infection
of monocytes with Cp BVDV altered the expression of multiple proteins involved in the
immune function of APCs including cell adhesion, apoptosis, antigen uptake processing
and presentation, acute phase proteins, and MHC molecules (Lee et al., 2009).
In macrophages infected with BVDV in vitro, there was reduced production of
superoxide anion (Adler et al., 1994) and the pro-inflammatory cytokine, TNF-α (Adler
et al., 1996) following LPS treatment. Fc receptor and complement receptor (C3R)
expression, phagocytosis and microbicidal activity, and the production of neutrophil
chemotactic factors were all reduced in macrophages recovered from BVDV-infected
calves (Welsh et al., 1995). Ncp BVDV infection diminished the expression of
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CD80/CD86 and MHC II antigen presentation molecules on the surface of peripheral
blood mononuclear cells (Archambault et al., 2000). The depression of T and B
lymphocytes in lymphatic tissues and peripheral circulation (Ellis et al., 1988; Brodersen
and Kelling, 1999) can inhibit cell-mediated and humoral immune responses in affected
cows.
3.2. BVDV-lymphocyte interaction and apoptosis induction
Total peripheral blood lymphocyte populations include both specific T and B
lymphocytes. T lymphocytes and their subpopulations are important for the induction of
cell-mediated immune response against BVDV infected cells. While B lymphocytes are
responsible for the induction of humoral immune response against BVDV mediated via
the production of neutralizing antibodies. Both humoral and cell-mediated immune
response is very important for viral clearance from the animal post-infection. In vitro
infection of peripheral blood lymphocytes with BVDV leads to induction of apoptosis in
these cells based on the virulence of the infecting strain. Moreover, in vivo BVDV
infection results in lymphoid depletion that may or may not be reversible based on the
virulence of the BVDV strain. (Ridpath et al., 2006; Chase, 2013).
During the acute infection, the initial infection takes place in the oronasal mucosa
and the virus spreads from this site systemically. BVDV invades the lymphoid tissue and
disables the recognition of effector functions of immunity with the subsequent capability
of persistence (Brownlie, 1990). The virus appears to be able to replicate in all the major
lymphocyte subpopulations as well as accessory cells. This may result in leukopenia that
is often a sequel of infection and affects B cells as well as the T-cell subpopulations
expressing either BoCD4 or BoCD8 antigens. B and T-cell responses are affected
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because of exposure to BVDV and there is a reduced ability to control other infections.
Although the fetus can mount an immune response in the latter part of gestation, during
the first trimester it does not. A specific state of tolerance is induced, and this is
associated with a change in the proportion of certain lymphocyte subpopulations and the
ability to respond to immune stimulation (Howard, 1990). T-lymphocytes numbers are
reduced following BVDV infection in a strain-dependent manner. There is the
recruitment of lymphocytes to the bronchial alveolar space following Cp BVDV
infection. Depletion of T-lymphocytes occurs in the lymphoid tissue and is straindependent. T-lymphocyte responses appear to be primarily a T helper 1 response while
the response following Ncp BVDV induces a T helper 2 response. (Chase, 2013). BVDV
infection leads to a severe reduction in the lymphocyte population as it affects both
thymic and follicular T-lymphocytes (Brewoo et al., 2007). Infection of calves with noncytopathic viral diarrhea virus (BVDV) resulted in the temporary suppression of
lymphocyte proliferation and interferon-gamma production leading to vaccination failure
against other infectious agents (Charleston et al., 2001).
BVDV is associated with immune suppression due to lymphoid depletion that can
be mild to severe, with variable levels of recovery depending on the virulence of the
BVDV strains (Ammari et al., 2012; Falkenberg et al., 2014; Liebler-Tenorio et al.,
2003). Interestingly, this lymphoid depletion was associated with an increased number of
macrophages 3 days post-infection in lymphoid tissues. The presence of this significant
number of macrophages in the lymphoid tissues suggests an indirect effect of this cell on
the lymphoid depletion caused by BVDV (Pedrera et al., 2009). Previously, the same
scenario has been proposed for the pathogenesis of classical swine fever virus (CSFV),
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another member of the pestivirus group in the Flaviviridae. CSFV can induce lymphoid
apoptosis directly and indirectly via macrophages. With CSFV, TNF-a production has
induced apoptosis (Choi et al., 2004). The Erns protein of CSF is responsible for
lymphocytic apoptosis (Bruschke et al., 1997). Recently, the involvement of apoptosisinduced cytokines, TNF-a and IL-1a, has been ruled out from BVDV pathogenesis
(Pedrera et al., 2009). Furthermore, the role of macrophages could be only restricted to
phagocytosis of apoptotic cell debris (Raya et al., 2012). Other groups have suggested
that most of the cells undergoing apoptosis after Cp BVDV infection are monocytes.
Also, Cp BVDV can induce apoptosis in purified CD4 T lymphocytes, which was
enhanced by the presence of monocyte in a mixed population, unlike CD8 T cells that
undergo apoptosis only in a mixed population with monocyte (Lambot et al., 1998).
Generally, there are 2 main pathways for induction of apoptosis: intrinsic and
extrinsic pathway, The apoptosis induced by cytopathic BVDV is associated with the
intrinsic but not the extrinsic pathway, especially due to the lack of caspase-8 expression
which is the main mediator for extrinsic pathway whereas caspase-9, which is an
important mediator of the intrinsic pathway, was strongly expressed (Hilbe et al., 2013).
Besides the two biotypes of BVDV, Cp, and Ncp, a third biotype has been proposed,
which is lympho-cytopathogenic and is associated with highly virulent strains. This third
biotype includes highly virulent Ncp biotypes that don't induce CPE on cultured
susceptible cells but induce apoptosis in cultured lymphoid cells (Ridpath et al., 2006).
There are many differences present between the 2 biotypes of BVDV that may affect the
mechanisms of viral pathogenesis. There are approximately 26 genes differentially
expressed between Cp and Ncp BVDV in the infected cell (Werling et al., 2005).
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Cytopathogenic BVDV exerts its cytopathic effect on the susceptible cells via apoptosis,
moreover, it has been proposed that this apoptosis is associated with the direct effect of
the virus on the infected cell rather than the interaction between infected and normal cell.
Cp but not Ncp strains can induce direct apoptosis to PBMCs (Zhang et al., 1996;
Lambot et al., 1998).
Previous literature has proposed many hypotheses for the apoptotic ability of
cytopathogenic BVDV. Some researchers suggested the involvement of NS3 as one of
the main differences between Cp and Ncp BVDV. This is along with higher levels of
RNA accumulation in Cp BVDV-infected cells than Ncp BVDV-infected cells (Vassilev
and Donis, 2000). The correlation between apoptosis and the cytopathogenic effect of the
virus was confirmed later by another group that discussed the role of apoptosis inhibitors
in delaying the cytopathogenic effect of BVDV (Grummer et al., 2002). Unlike Cp
BVDV, the Ncp BVDV inhibits both IFN I synthesis and RNA accumulation and
subsequently induced apoptosis in the infected cell. It has been thought that this
inhibition is mediated through the specific interfering with the intracellular action of
accumulated ds RNA but not with its uptake into the cells (Schweizer and Peterhans,
2001). Interestingly, the infection of monocyte/macrophage with Cp BVDV leads to
upregulation of crucial chemokines of CCL and CXCL families that are important in the
induction of proper immune response against the infection. In contrast. Ncp BVDV
downregulated such important chemokines (Burr et al., 2012). Proper activation of
PBMCs in response to BVDV infection can protect them against apoptosis via TRAF2
dependent CD 28-4-1BB signaling (Song et al., 2016).
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Several studies reported a significant leukopenia and lymphopenia followed acute
infection including both B and T lymphocytes in peripheral blood (Brodersen., 2014;
Hassan et al., 2018). Further, during BVD infection, cytotoxic CD8+ T lymphocytes will
be more depleted than the helper CD4+ T lymphocytes with less or no harm to circulating
γ/δ T-cells. The CD4+ lymphocyte depletion increases the period of virus shedding.
Therefore, BVD infection could increase the susceptibility to other secondary microbial
infections because the lymphocytes from diseased animals will have impaired memory
responses to BVDV and other antigens (Liebler et al., 2003; Ridpath et al., 2006). In the
fetal animal, CD3 positive lymphocytes clustered in numerous, small aggregate
populations near Kupffer cells at 89 days in gestation in both PI and control samples.
Since only the Kupffer cells (liver macrophages) are infected with BVDV at this stage of
gestation they may affect lymphocyte development and contribute to the development of
PI infection (Morarie-Kane et al., 2018).
Other studies showed that BVDV infection was responsible for the thymic lesions
observed in the infected animals as well as for the majority of immunopathologic
changes, including downregulation of Foxp3 lymphocytes and TGFβ, which reverted as
BVDV was cleared (Romero‐Palomo et al., 2017). Thymus depletion was also observed
for the Ncp vaccine and Ncp-field-stain exposed calves and the virus biotype, method of
attenuation, presentation, and use of adjuvant will influence vaccine impacts on lymphoid
tissues and the immune response (Falkenberg et al., 2020).
Unlike Ncp BVDV, Cp biotypes express non-structural protein 3 (NS3) which
induced apoptosis in infected cells but doesn't inhibit interferon-beta production (Gamlen
et al., 2010). Cp-BVDV-infected cells generally demonstrate the classical signs of
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apoptotic cell death. Several reports have shown that the Cp strains induce apoptosis by
cleaving genomic DNA to nucleosomal lengths, activating caspases, reducing the
mitochondrial membrane potential with the release of cytochrome c into the cytoplasm of
the infected cell, or triggering the dsRNA response (Bendfeldt et al., 2003; Yamane et al.,
2008).
Furthermore, other studies also suggested that Cp and Ncp BVDV infection in
autophagy-knockdown MDBK cells increased apoptotic cell death and enhanced the
expression of the mRNAs for IFN-α, Mx1, IFN-β, and OAS-1 as compared with control
MDBK cells (Zhou et al., 2017).
In general, it has been observed that the high virulent strain of BVDV seems to be
acting as a less acute "killer," promoting a high apoptotic rate sustained over time
(Malacari et al., 2018). The interpretation of the role of apoptosis and necrosis of PBMC
in the pathogenicity of several viruses including BVDV has changed over the last 10
years. Multiple forms of regulated necrosis have a key role in pathologies such as sepsis,
inflammatory diseases, and infectious disorders. The pattern of apoptosis/necrosis
induction may be regulated by TNF-α while the production of TNF-α can be associated
with BVDV virulence (Palomares et al., 2014). Further experiments are needed to clarify
the relationship between TNF-α and BVDV-2 virulence and the possibility of assessing
virulence by measuring apoptosis rates of in vitro infected PBMC.
3.3. BVDV-neutrophil interaction
Neutrophils are one of the predominant white blood cells in circulating blood and
are considered the first line of defense in the innate immune system (Kobayashi and
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DeLeo 2009) along with macrophages. Neutrophils play an important role against
invading bacteria and, initiate innate as well as adaptive immune responses. Neutrophils
activate innate immune response through various mediators including interleukin-8 (IL8),
platelet-activating factor (PAF), leukotriene B4 (LTB4), or complement fragment 5a
(C5a) (Guo et al. 2003, Mitchell et al. 2003, Mantovani et al. 2011, Mitchell et al. 2014).
The ability of neutrophils to migrate and destroy the invading microorganism depends
upon their expression of surface markers including a cluster of differentiation (CD) -14
(CD14), CD-18, and L-selectin (Yoshitake et al. 2002). Viruses affecting the neutrophil
surface markers can significantly affect the host immune defense mechanism. Normally,
neutrophils are present in the circulation in a resting state, which ensures that their
oxidative intracellular contents are not released to damage the host tissue (Wright et al.
2010). During acute inflammation, neutrophils become activated and kill the invading
organism (mainly bacteria) and help in shaping adaptive immune response (Kasama et al.
2005, Jaillon et al. 2013). Neutrophils activate the adaptive immune system through proinflammatory cytokines and chemokines including tumor necrosis factor-alpha (TNF α),
interleukin-1β (IL-1β), interleukin-8 (IL-8), interleukin-6 (IL-6), interferon-inducible
protein 10 (IP-10), and macrophage inflammatory protein (MIP)-1α (Altstaedt et al.
1996, Kasama et al. 2005). Neutrophils become activated via a two-stage process: 1)
priming and 2) mobilization. Priming occurs by exposure to invading bacterial products
or the cytokines/chemokines, TNF-α, GM-CSF, IL-8, IFN-γ, and /or MIP-1 (Hallett and
Lloyds 1995, Mercer-Jones et al. 1999). This rapid priming occurs within minutes after
receiving the signals. The primed neutrophils have an extended life span. Activated
neutrophils are mobilized to the site of infection by chemoattractants N-formyl
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methionyl-leucylphenylalanine (fMLP) or complement component 5a (C5a). These
chemoattractants induce cellular polarization to make actin-rich pseudopodia, which
helps in their movement (Servant et al. 2000). The formation of pseudopodia also helps in
phagocytosis and destroying invading bacteria through intracellular phagosome and
reactive oxygen species (ROS) (Lee et al. 2003).
In addition to these strategies, neutrophils also use neutrophil extracellular traps
(NET) to destroy larger pathogens that cannot be phagocytized (Segal 2005, Halverson et
al. 2015). The process of NET formation is NETosis. NETosis is distinct from apoptosis
and necrosis and is defined as the release of nuclear DNA, DNA-associated proteins, and
lactate dehydrogenase (LDH) from an activated neutrophil into the extracellular
environment (Kawasaki and Iwamuro 2008, Urban et al. 2009, Brinkmann and
Zychlinsky 2012). NET also contains primary, secondary, and tertiary granular
components that include neutrophil elastase, cathepsin G, and myeloperoxidase (MPO)
(Urban et al. 2009, Brinkmann and Zychlinsky 2012), lactoferrin, and gelatinase
(Borregaard 2010). Among all the components, histones proteins are the most abundant
component and act as a potent antimicrobial agent (Kawasaki and Iwamuro 2008, Urban
et al. 2009). During NET formation, the nuclear envelope degrades and the mixing of
nuclear DNA with cytosolic proteins takes place, which then extrudes from the cell to
trap the invading pathogen. NET can be induced by the treatment of neutrophils with
interleukin- 8 (IL-8), phorbol 12-myristate 13-acetate (PMA), lipopolysaccharide (LPS),
bacteria, fungi, or activated platelets. Some viruses also induce NET formation including
influenza A virus, HIV-1 virus, myxoma virus, encephalomyocarditis virus, and
respiratory syncytial virus (Narasaraju et al. 2011, Saitoh et al. 2012, Jenne et al. 2013,
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Funchal et al. 2015). BVDV infection reduced the number and functional ability of both
granulocytes as well as monocytes (Brewoo et al. 2007). BVDV infection significantly
reduced the number of circulating neutrophils (Roth et al. 1981, Brown et al. 1991,
Ganheim et al. 2005) with reduced degranulation and impaired myeloperoxidase,
hydrogen peroxide, halide antibacterial activity (Roth et al. 1981). Similarly, vaccination
with BVDV modified live virus vaccine (MLV) significantly reduced circulating
neutrophils, suppressed iodination, and antibody-dependent cell-mediated cytotoxicity
(ADCC) activity (Roth and Kaeberle 1983). High (HV24515) and low virulent (LV11Q)
Ncp BVDV-2 infection induced severe neutropenia after viral inoculation. The number of
neutrophils returned to normal, but recovery was delayed in calves infected with high
virulence virus as compared to low virulence (Keller et al. 2006). Neutrophils from cattle
PI with BVDV were characterized by a significant decrease in random migration,
bacterial ingestion, oxidant production, and antibody-independent cell-mediated
cytotoxicity (Brown et al., 1991). There was also a significant decrease in
polymorphonuclear leukocytes (PMN) respiratory burst and cellular enzymes NAGase
and lysozyme in PI heifers (Piccinini et al., 2006).
Several studies have been done to study the effect of BVDV on chemokines (Burr
et al. 2012) and pro-inflammatory cytokines (Schweizer and Peterhans 2001,
Fredericksen et al. 2015). Multiple cytokines (IL-1β, IL-8, IL-15, IL-18, Mx-1, IFN
gamma), which recruit or activate neutrophils, have been studied (Hammond et al. 1995,
Leung et al. 2001, Verri et al. 2007). It was reported that only highly virulent Ncp
BVDV2a significantly increased the apoptosis in neutrophils. Regardless of the virulence
all BVDV strains reduced CD18 and L-selectin surface expression, oxidative burst, and
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neutrophil extracellular traps (NET) activity. Cp BVDV significantly reduced the
neutrophil's phagocytic activity, but Ncp BVDV strains did not affect phagocytosis. Ncp
BVDV significantly increased neutrophil CD14 expression and chemotactic activity
while Cp BVDV had no effect (Thakur et al., 2020).
4. BVDV in bison
BVDV has a wide range of ruminant hosts and has been reported in both
domesticated and wildlife with a remarkable high infection rate for those animals that are
in the agricultural interface. BVDV has been isolated in other species than cattle that
include, but are not limited to, sheep, goat, pig, antelope, and bison (Nelson et al., 2016;
Wolff et al., 2016; Van Campen and Rhyan, 2010). The wild-life isolated BVDV is
indistinguishable from bovine isolates and can infect cattle with the typical forms of
BVDV infection and mild clinical signs (Deregt et al., 2005). Bison are infected with
both BVDV-I and BVDV-II with a wide range of symptoms that included mucosal and
peracute disease. The infection in bison, like cattle, can be vertical or horizontal and the
risk of developing a persistently infected animal is possible (Deredet et al., 2005; Hause
et al., 2021). The two main factors believed to favor the spread of infection in bison are
the presence of PI animals and being near a cattle herd (Hause et al., 2021).
5. Bosavirus
Bosavirus is a novel parvovirus that has been first identified as a cell culture
contaminant in a pooled fetal bovine serum with the aid of metagenomic analysis that
included DNase digestion. Bosavirus was DNase resistant. (Sadeghi et al., 2017). It is a
small, single-stranded, non-enveloped virus with a short 5-6 kb genome. Its genome
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contains two open reading frames (ORFs) that encode nonstructural proteins that help in
virus replication and capsid formation. Bosa virus is classified under family,
Parvoviridae, and contains 2 subfamilies: Parvovirinae infecting vertebrates and the
Desovirinae that infect arthropods. The Parvovirinae contains eight different genera (Liet
al., 2015; Sadeghi et al., 2017; de Souza et al., 2018). Out of these 8 genera, Bosavirus
has been classified under genus Copiparvovirus together with 6 other species (total of 7
species). Out of these seven species, two were identified in cattle (Ungulate
copiparvovirus 1 and 5). The Copiparvovirus genus is closely related to bovine
parvovirus 2 (BPV2); as it has 41% identity to the non-structural protein NS1 and 47%
identity to the virus capsid protein of BPV2 (Cotmore et al., 2019). Bosavirus was
identified in BVDV persistently infected cattle during the investigation of the bovine
virome (Weber et al., 2018). A Bosavirus has been recently identified in American bison
(bison bosavirus) and was closely related to bovine Bosavirus that formed a sister clade
together to place bison bosavirus under copiparvovirus genus (Hause et al., 2021). The
etiological significance of most Copiparvoviruses is still unknown and further work
needs to be done to reveal their significance.
6. Primary cells and cell lines
Primary cell culture is obtained directly from parental tissue of interest, in
contrast to the cell line that is a modified descendant of the primary cell culture, which is
generally used to expand cell population and prolong cell life span in culture. Each
culture system has some advantages and disadvantages. The primary cell system is
biologically relevant as it resembles parental origin with a minimal mutation that makes it
quite like the tissue of interest, unlike cell line that encountered a lot of mutation down
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the road that eventually makes them not represent the original tissue leading to false
results, after a long time of passage. On the other hand, passaging and subculture is not
an attribute of primary cells as these cells have a finite number of cell cycles after which
they can't divide and grow so it is difficult to maintain primary cells. Obtaining primary
cells is multi-step, laborious process with a high risk of contamination, and usually ends
with a mixed rather than single population of cells. However, developing “good” primary
cells can be accomplished in a laboratory that is meticulous and specializes in primary
cell development. Another advantage of primary cells over cell-line is the chance to study
and investigate in vitro donor cells, to predict the outcome of new drugs and
pharmaceutical products. It is important to use primary cells for in-depth investigation of
certain biological processes in vitro to get reliable data (Butler et al., 2004; Berg et al.,
2002).
SUMMARY
Bovine viral diarrhea virus (BVDV) is an endemic viral disease of cattle that
continues to threaten North American farms. Symptom-wise, acute BVDV infection is
considered a mild disease of cattle, however, its impact on the immune system is
profound. BVDV causes severe immune dysfunction in the infected animal, which favors
secondary infection that can have a negative impact on animal health, and consequently
affects animal productivity. The immune dysfunction condition following BVDV
infection is a major concern in cattle operations as it can lead to the secondary infections
and/or vaccination failure that will negatively impact the economics of the cattle farms.
The current control strategy, which is mainly based on vaccination, is insufficient to
prevent continuous BVDV spread and needs to be improved. The key to improving the
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current control protocol is to better understand how BVDV manipulates the immune
system of the infected animals and leads to immune dysfunction.
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Figure 1.1. BVDV genome structure: showing 4 structural and 7-8 nonstructural proteins.
C: Capsid protein, E: enveloped glycoproteins, NS: nonstructural
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CHAPTER 2
IMMUNOLOGICAL STUDIES ON BVDV-INFECTED MACROPHAGE
SUPERNATANT
ABSTRACT
Bovine viral diarrhea virus (BVDV) induces immune dysfunction that often
results in a secondary bacterial infection in the infected animals. The underlying
mechanism of this general immune dysfunction is not well understood. Based on
preliminary results (Abdelsalam et al., 2020) , we believe that the macrophage plays an
important role in mastering the immune dysfunction effect of BVDV. In the current
study, we have attempted to exclude some of the possible factors in the infected MDM
supernatants that initiate lymphocyte apoptosis, and we extended the investigation of
infected MDM supernatants to include testing its impact on neutrophil viability, surface
marker expression, and functional activity. BVDV-infected MDM supernatants did not
impact neutrophil viability 6 h post-treatment, however, they down-regulated surface
marker expression either significantly as in the case of L-selectin or non-significantly as
in the case of CD18. Interestingly the supernatants had no significant effect on neutrophil
phagocytic activity nor oxidative burst. Additionally, it appeared that Cp BVDV-infected
supernatant managed to significantly down-regulate nitric oxide production and
neutrophil extracellular traps (NET) induction in pre-stimulated cells. On the other hand,
no apoptosis-related cytokines were detectable in all infected supernatants, and the viralprotein-depleted supernatants were still capable of inducing lymphocyte apoptosis. In
conclusion, our data suggested an important role of macrophages in the mechanism of
immune dysfunction that extended to include neutrophil surface marker and functional
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activity. Unlike lymphocyte apoptosis that depends on the virulence of the BVDV strain,
the negative impact on neutrophil functional activity seems to be more biotype specific,
especially the Cp BVDV. Our data also suggested the exclusion of both viral proteins and
pro-inflammatory cytokines in inducing lymphocyte apoptosis, however further studies
are required to determine the identity and mechanism of action of these apoptotic factors
present in the supernatant of the infected macrophages.
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INTRODUCTION
Bovine viral diarrhea virus (BVDV) causes immune dysfunction in infected cattle
and other ruminants resulting in severe economic losses (Hay et al., 2016; Richer et al.,
1988; Risalde et al., 2011). Immune dysfunction associated with BVDV infection has
been suggested to be in part a consequence of lymphoid depletion that depends on the
virulence of BVDV strains (Ammari et al., 2012; Bittar et al., 2020; Falkenberg et al.,
2014; Liebler-Tenorio et al., 2003). Most BVDV infection in the field ends with a severe
secondary bacterial infection that may also suggest a potential immune suppressive effect
of BVDV on neutrophils, the major innate immune defense against bacteria.
While only Cp strains of BVDV induce direct apoptosis to lymphocytes (Lambot
et al., 1998; Zhang et al., 1996), most of the field BVDV infections are the result of Ncp
strains and are associated with severe lymphoid depletion (Ammari et al., 2012; Bittar et
al., 2020; Falkenberg et al., 2014; Liebler-Tenorio et al., 2003Pedrera et al., 2009;
Romero–Palomo et al., 2017). Cp BVDV-induced apoptosis has been associated with
soluble factors produced by monocyte-like cells that induced apoptosis in uninfected cells
after lipopolysaccharide (LPS) treatment, [Adler et al., 1997; Lambot et al., 1998;
Schweizer et al., 1999 Zhang et al., 1996). These soluble factors (s) had not been
characterized in the previous studies. Cytokines have been reported as one of these
factors that prime apoptosis, which includes, TNF-α, IFN-γ, and IL-1beta (Adler et al.,
1996; Aldo et al., 2020; Choi et al., 2017; Lopez et al., 2020).
Certain Ncp strains of BVDV have been assigned to a new biotype category
"lymphocytopathogenic", where they induce apoptosis in lymphocytes but not the target
epithelial cells (Falkenberg et al., 2014, Ridpath et al., 2006). In addition, Ncp BVDV has
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been reported to induce apoptosis in vitro in PBMCs isolated from BVDV-infected
animals (Risalde et al., 2020). However, the mechanism by which
Ncp/lymphocytopathogenic BVDV strains induced their apoptotic effect is not well
characterized.
Many immune cells including macrophages are susceptible to BVDV infection in
vitro (Adler et al., 1994; Archambault et al., 2002). However, infected macrophages
failed to produce infectious progeny (Elmowalid, 2003; Rajput et al., 2014). Several
studies suggest the role of macrophages in lymphoid depletion and immune dysfunction
associated with BVDV. These studies demonstrated the importance of macrophage in
lymphocyte apoptosis in a mixed population of PBMCs (Lambot et al., 1998; Pedrera et
al., 2009). Other studies reported that the Pestivirus' specific Erns glycoprotein can be
secreted and could play a role in the apoptosis mechanism associated with CSFV
(Bruschke et al., 1997; Fetzer et al., 2005).
While several studies demonstrated the impact of BVDV on immune cells that
influence the adaptive immune response including macrophages (Chase et al., 2004),
little is known about the effect of BVDV on neutrophils. Neutrophils are one of the most
abundant white blood cells (WBC) in the blood, which play a critical role in the innate as
well as adaptive immune response They are considered the first line of innate defense
against different pathogens especially the bacteria (Kobayashi and DeLeo, 2009).
Neutrophils non-specifically engulf the invading pathogens and initiate the innate and
activate the adaptive immune response (Jaillon et al., 2013) through various mediators
including interleukin-8 (IL-8), platelet-activating factor (PAF), leukotriene B4 (LTB4),
and complement fragment 5a (C5a) (Guo et al., 2003; Mantovani et al., 2011; Mitchell et
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al., 2003; Mitchell et al., 2014). The functional activity of neutrophils depends on their
surface maker expression especially CD14, CD18, and L-selectin. CD14 helps in
bacterial recognition especially gram-negative bacteria as they are considered endotoxin
receptors (McAvoy et al., 2011), while CD18 and L-selectin help in cell adhesion,
diapedesis, and receptor-mediated homing to the local site of infection (Gao and Issekutz,
1996; Gomez and Doerschuk, 2010; von Andrian et al., 1993). Several studies reported
that viral infections altered surface marker expression on innate immune cells. (Thakur
2017, Rajput et al., 2014 and Abdelsalam et al., 2020). Nonetheless, BVDV infects
neutrophils and decreases their surface marker expression, phagocytic, microbicidal
activity, and migration (Thakur et al., 2017; Potgieter et al., 1995; Roth et al., 1981; Roth
et al., 1986; Sopp et al., 1994).
The current study aimed to investigate the immune dysfunction mechanism
induced by BVDV infection that favors the secondary bacterial infection in the field. The
main objectives of this study are to: 1) Identify the soluble factors of the infected
macrophage that induce lymphocyte apoptosis. 2) Examine the impact of these soluble
factors on neutrophil viability, surface marker expression, and functional activity of
neutrophils to investigate a possible immune cell interaction in response to BVDV
infection.
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MATERIAL AND METHODS
Animal
Healthy Holstein Friesian heifers (6-8 months of age) housed at the Dairy Farm,
South Dakota State University (SDSU), Brookings, SD, USA were used in this study.
The SDSU Institutional Animal Care and Use Committee (IACUC) approved animal
handling and blood collection. The animals were confirmed as BVDV-free by BVDVspecific immune-peroxidase assay (Fulton et al., 1997).
Virus
Three strains of BVDV were used: BVDV 2a high virulence 1373, BVDV 2a low
virulence 28508, and 296C (Ridpath et al., 2016). These strains were already prepared
and were preserved at -80. All strains were previously titrated, and their titer was
recorded in the virus logbook (Table 2.1.).
Madin Darby bovine kidney (MDBK) cells
BVDV-free MDBK cells (passage 76-85) were grown in minimal essential
medium (MEM, Gibco BRL, Grand Island, NY) supplemented with 10% BVDV-free
fetal bovine serum (FBS) (Hyclone Laboratories, Logan, UT), penicillin (100 U /ml) and
streptomycin (100 μg/ml). MDBK cells were maintained at 37°C with 5% CO2 in the
humidified incubator and were used for viral titration and propagation.
Isolation of peripheral blood mononuclear cells
Peripheral blood mononuclear cells (PBMCs) isolation was done following the
method of Rajput et al (Rajput et al., 2014) with modifications. Briefly, whole blood was
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collected from 6-8-month heifers, using a sterile syringe containing 1 ml of 1000 U/ml
heparin sulfate (Sigma, Sigma Chemicals, St. Louis, MO, USA). The heparinized blood
was diluted 1:1 with PBS and overlaid on SepMate™ 57 lymphoprep 50 ml tubes
(Stemcell Technologies, Cambridge, MA, USA) gradients and centrifuged at 1200 Xg for
20 min at room temperature (RT) using a Beckman J6-MI centrifuge. After
centrifugation, the plasma and buffy coat layer were poured into a clean 50 ml conical
tube (Falcon, Oxnard, CA, USA). The buffy coat was washed 5 times with PBS followed
by centrifugation at 120 Xg for 10 min at RT. The viability of PBMCs was determined by
trypan blue exclusion assay using 0.4% trypan blue stain (Strober, 2001). The following
formula was used to calculate the cell viability of the monocytes: Cell viability % =
number of viable cells (unstained cells) - trypan blue-stained cells) X 100/Total counted
cells. The PBMCs were resuspended in complete RPMI 1640 medium (GE Healthcare,
Hyclone Laboratories, Logan, UT, USA) supplemented with 10% FBS, penicillin (100
U/ml), and streptomycin (100μg/ml) to achieve a final concentration of 1X106 cells/ ml.
Twenty mL of cells were incubated in T175 Flask (Corning, NY, USA) for 3 h at 37˚C.
Plastic adherence-based monocyte separation and morphological identification
The monocytes were isolated from the total PBMCs by the plastic adhesion
method according to (Mwangi et al., 2005, Rajput, 2014) with modifications. Following
incubation for 3 h at 37˚C, the floating cells were discarded, and flasks were washed 5
times with PBS and the wash was discarded. The adherent cells were detached with
Accutase™ (eBioscience, San Diego, CA, USA). Detached cells were washed two times
by suspending them in PBS and pelleting by centrifugation at 120 Xg for 10 min at RT. A
sample from detached cells was submitted to Hema true blood analyzer (Heska Corp.,
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Loveland, CO, USA) and the detached cells were identified as monocytes with a
characteristic kidney shape nucleus by H&E stain (data not shown).
Peripheral blood monocytes-derived macrophages (MDM)
MDM were cultured as described by Elmowalid, 2003 with modifications.
Briefly, the adherent monocytes were cultured in RPMI 1640 (GE Healthcare, Hyclone
Laboratories, Logan, UT, USA) supplemented with 10 % FBS, penicillin (100 U/ml), and
streptomycin (100μg/ml) at a final concentration of 1x 105 cells/ well in 48-well plate
followed by incubation for 7 days at 37˚C in CO2 incubator. The incubated cells were fed
every other day simply by replacing half of the conditioned media with fresh complete
RPMI. On the 7th day, the MDM were characterized phenotypically as MHCI, MHCII,
CD11b, and CD14 positive for at least 84% of the cells. This was done as described by
Rajput, 2013. Briefly, MDM was detached using Accutase™ (eBioscience, San Diego,
CA, USA), washed with PBS, and pelleted by centrifugation 1000 Xg for 10 min at RT.
The number of the cells was adjusted to 1x106 /ml. Four primary mouse mAb antibodies
for MHC-I (H58A), MHC-II (H42A), CD11b (MM10A), and CD14 (MM61A)
(Monoclonal Antibody Center, WSU, Pullman, WA, USA) were used to characterize the
cells. Cells were incubated with 50µl of diluted primary antibodies 1:100 in PBS
containing 1% FBS at 4°C for 10 min followed by washing with PBS. This was followed
by staining with 1:1000 in PBS diluted FITC labeled anti-mouse secondary antibody
(VMRD Inc., Pullman, WA, USA, containing 1% FBS, at 4°C for 10 min. The stained
cells were washed two times with PBS and were fixed with 200µl of 1%
paraformaldehyde. The percentage of cells expressing surface markers was calculated
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using BD Accuri™ C6 Plus Flow Cytometer (BD Biosciences, CA, USA). (Data not
shown).
Fresh lymphocyte culture
The PBMCs were isolated as described above and monocytes were removed by
adhesion to plastic for 3 h at 37°C in a CO2 incubator. The non-adhesive cells were
collected and washed 3 times by PBS and centrifuged at 120 Xg for 10 min at RT to
remove the platelets. The pelleted lymphocytes were suspended in RPMI 1640 medium
supplemented with 15% FBS, penicillin (100 U/ml), and streptomycin (100μg/ml) to
achieve final a concentration of 1x 105 cells/ ml followed by culturing in a 24-was ell
plate with a seeding density of 1 ml/well. The plate was then incubated at 37°C for
further apoptosis testing.
BVDV infection of MDM
MDM were infected with one of 3 different strains of BVDV, 1373, 28508, and
296C in triplicate as described by Elmowalid, 2003 with modifications. Briefly, the
MDM were infected at a multiplicity of infection (MOI) of 1 by diluting the virus stock
with RPMI 1640 medium. Seven-day-old MDM washed with 1x PBS to remove old
medium containing floating dead cells then infected with diluted virus strain with 1X105
TCID50 at MOI of 1 in a final volume of 100 µl. The infected cells were incubated for 1
h then washed again to remove the excess unbound virus and 500 µl of complete RPMI
1640 medium was added to each well. At least one column of the plate was mockinfected with a complete RPMI 1640 medium as a negative control. The infected MDM
were incubated for 48 h at 37°C in a CO2 incubator.
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Supernatant collection and irradiation
Supernatant collection and treatment were done as described by Elmowalid, 2003
with modifications. Briefly, the infected macrophage supernatants of the three BVDV
strains were collected 48 h p.i in 15 ml conical tubes. The supernatant was centrifuged at
1000 Xg for 10 min at RT to remove cellular debris. After dispensing each strain
supernatant in 100x15 mm polystyrene sterile square Petri dishes (Falcon, Oxnard, CA,
USA), the supernatant was treated by UV irradiation at 15 cm for 20 min on ice to
inactivate the virus (Perler et al., 2000; Jungmann et al., 2001). The absence of any
infectious viral particles in the treated supernatants was confirmed by IP assay and the
result was contrasted to a positive 1373 infected MDBK (Figure 2.4). The UV-irradiated
supernatants specific for each strain of BVDV were aliquoted and stored at -20°C.
Supernatant immune precipitation and lymphocyte treatment
This assay was done to determine the role of soluble viral proteins like Erns and
Ns proteins in initiating apoptosis in the lymphocyte population. To achieve that,
Dynabeads™ Protein A and Magnet Starter Pack (Thermo Fisher Scientific, Waltham,
MA, USA) were used. Simply, Erns specific 15c5 monoclonal antibody (IDEXX
Laboratories, Westbrook, ME, USA) or BVDV-polyclonal antibody (Kindly supplied by
Dr. Robert Fulton, Food Animal Research, Oklahoma State University) were conjugated
overnight with Dynabeads coated with protein A at RT. The next day, the irradiated
supernatants from 296 C and 1373 infected MDM which (was proven to induce
lymphocyte apoptosis) were incubated with the conjugated beads in a test tube for 2 h at
37oC. After that, a magnetic force was applied to the side of the test tube containing the
beads and the remaining supernatant (without beads) was transferred to another test tube.
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The viral-protein-depleted supernatants specific for each virus strain was used to treat
fresh plated lymphocyte culture by adding three parts of the supernatant to one part of
fresh lymphocyte culture seeded at 1x105 cells/well, then the treated culture was
incubated at 37˚C for 36 h post-treatment. Cp BVDV-infected lymphocyte control, whole
supernatant control (the initial irradiated supernatant without bead precipitation), mockinfected controls (complete RPMI 1640 only) as well as 1 μmol of staurosporine (STS)
that serve as positive apoptotic control in respective wells (Belmokhtar et al., 2001) were
also included. This was followed by lymphocyte apoptosis testing by Annexin V staining.
Apoptosis analysis using Annexin V staining
This was done using the AnnexinV staining kit (eBioscience, San Diego, CA,
USA). Briefly, the infected, or supernatant treated lymphocytes were washed once with
1X PBS, and the cells were spun down at 1000 Xg for 10 min and resuspended in 100µl
of 1X the binding buffer supplied by the kit as 4X stock solution. Five (5) µl of FITC
conjugated annexin v antibody was added to the lymphocytes suspended in 100µl of
binding buffer and incubated for 10 min in dark. This was followed by washing the cells
twice by suspending the cells in 1X binding buffer followed by centrifugation of the cells
at 1000 Xg for 10 min. The washed cells were resuspended in 200µl of 1X BD FACS™
lysing solution followed by analysis with BD Accuri™ C6 Plus Flow Cytometer (BD
Biosciences, CA, USA). The result was expressed as % of apoptosis.
Proinflammatory cytokine ELISA
This assay was performed to determine the possible role of pro-inflammatory
cytokines produced by infected MDM in initiating lymphocyte apoptosis. To achieve
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that, the level of TNF-alpha and IL-1 beta were measured in the infected MDM
supernatant specific for each virus strain in comparison to the Mock-infected-MDM
supernatant control. Two (2) μg/mL LPS treated MDM supernatant was also included as
a positive to act as a positive control. Bovine IL-1 beta ELISA kit (Thermo Fisher
Scientific, Waltham, MA, USA) with a 0.85-250 pg detection range and Bovine TNFalpha DuoSet ELISA kit (R&D Systems Minneapolis, MN, USA) with 125-8000 pg
detection range were used according to manufacturer’s instructions. Simply the samples
as well as the kit standards were added to the pre-coated TNF-alpha or IL-1 beta plate
and incubated for 1h at RT before washing three times with the kit wash buffer. This was
followed by adding 100 μl of biotinylated detection anti-body and incubation for 1h at
RT. The plates were washed again 3-4 times with the kit wash buffer. 100 μl of
streptavidin- HRP conjugate was added and incubated for an additional hour at RT before
washing 3-4 times with the kit wash buffer. 100 μl TMB substrate was added, and the
plates were incubated for 25 min at RT protected from light. The reaction was stopped by
adding 100 μl of TMB stop solution and the plates were read at 450 nm wavelength by
ELISA reader (Biotek, ELx808, Winooski, VT).
Mass Spectrometry Sample Preparation
The infected MDM lysate was submitted for Mass Spectrometry Analysis
(USDA, Ames, IA, USA). Briefly, the BVDV-infected MDM of each strain was
collected at 48 h p.i and washed 3 times with PBS. At least 5x 106 cell/ml was harvested
for each treatment. The cell pellet was flash-frozen under liquid nitrogen vapor and sent
overnight for Mass spec analysis.
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Neutrophil Isolation
To isolate neutrophils, fifty (50) ml of peripheral blood was collected in 10 ml
heparinized vacutainer tubes (BD, Franklin Lakes, New Jersey, USA) following IACUC
guidelines. The neutrophils along with red blood cells (RBCs) were separated by
centrifuging the blood at 1,000 X g for 30 minutes at 25°C. The plasma and buffy coat
were removed and discarded. The cell pellet was placed into 15 mL conical tubes and 10
mL of RBC lysing solution was added. The tube was gently inverted several times for 10
minutes to lyse the RBCs. After gentle inverting, the tube was centrifuged at 1,000 X g
for 5 minutes at 25°C. Supernatants were discarded and cells pellets were washed 3 times
using 10 mL of HBSS (the tubes were centrifuged at 1,000 X g for 5 minutes at 25°C).
The final cell pellet was suspended in 10 mL RPMI 1640 medium (MEM, Gibco BRL,
Grand Island, NY) supplemented with 10% BVDV-free fetal calf serum (FCS) (PPA,
Pasching, Austria), sodium pyruvate, penicillin (100 U/ml) and streptomycin (100μg/ml)
(Sigma-Aldrich, St. Louis, MO, USA). Freshly collected neutrophils were examined for
viability through trypan blue exclusion assay and CyQUANT™ LDH Cytotoxicity
Assay. The purity of the isolated neutrophils was also tested via a Hema-true blood
analyzer (Heska Corp., Loveland, CO, USA). Only freshly collected neutrophils with 9598% purity and >90% viability, were used for further testing (Data not shown).
Neutrophil treatment with infected MDM supernatant and viability testing
To determine the effect of different BVDV-infected MDM supernatants on
neutrophil viability, freshly collected neutrophils were suspended in RPMI 1640 medium
supplemented with 10% FBS, penicillin (100 U /ml) and, streptomycin (100 μg /ml) to
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achieve final concentration 1x106 /ml. One ml of the cell suspension was added to each
well of the 24-well plates. After the cells were settled, their media were carefully
removed and replaced with 200 μl of different MDM supernatant treatment. Mockinfected MDM supernatant or lipopolysaccharide-treated (LPS; 2 μg/mL) (SigmaAldrich, St. Louis, MO, USA) neutrophils were used as negative or positive controls
respectively. Samples were collected at 0, 1, 3 or,6 h pi and examined for their viability
using trypan blue exclusion assay together with CyQUANT™ LDH Cytotoxicity Assay
Kit according to manufacturer’s instructions. LDH is a cytosolic enzyme that will be
released only from damaged cells (due to increased membrane permeability) to the
outside medium that will convert the lactate in the medium into pyruvate in a coupled
reaction that includes the reduction of NAD+ into NADH. The latter will be oxidized
back to NAD+ in the presence of Diaphorase that will lead to the reduction of watersoluble tetrazolium (INT) into a red Formazan product that can be measured in an ELISA
reader at a wavelength of 490 nm. Briefly, each sample will be examined in a set of
triplicate wells. an additional set of triplicate wells containing medium only will serve as
spontaneous and maximum LDH release control. To the set of triplicate wells serving as
the Maximum LDH Activity Controls, add 20 µL of 10X Lysis buffer, then mix by gentle
tapping while for the spontaneous LDH control, 20 μl of ddH2O was added. The plate
was incubated at 37°C with the appropriate level of CO2 for 45 minutes. Fifty (50) µL of
each sample medium (Spontaneous LDH Activity, Maximum LDH Activity, and
Chemical-treated LDH activity) was transferred to a 96-well flat-bottom plate in triplicate
wells. Fifty (50) µL of Reaction Mixture was added and mixed with each sample well.
The plate was incubated at RT for 30 minutes, protected from light. Fifty (50) µL of Stop
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Solution was added to each sample well and mixed with gentle tapping. Absorbance was
measured within 1 to 2 h at 490 nm and 680 nm. To determine LDH activity, the 680-nm
absorbance value (background signal from the instrument) was subtracted from the 490nm absorbance value for each sample in triplicate and the average OD values were
calculated. The methanol-treated neutrophil group was included as a positive cell death
control. The following equation was used to calculate the viability % of neutrophils:
Neutrophil viability % = 1- [(sample OD value- spontaneous LDH OD value)/
(Max LDH OD value- spontaneous LDH OD value)] x 100.
Immunostaining and Flow Cytometry of Neutrophil Surface Markers
The expression of CD14, CD18, or L-selectin markers, on the surface of bovine
neutrophils, was measured in response to different treatments with infected MDM
supernatants, including the 3 BVDV strain-specific MDM supernatants, mock-treated and
LPS (2 μg/mL) positive control according to Elmowalid, 2003. Briefly, neutrophils from
each treatment group were collected 6hpost-treatment and centrifuged for 5 min at 1500
rpm at room temperature (RT). Cell numbers were adjusted to 1x106 /ml in PBS
containing 1% FBS. A 100 µl cell suspension was added to each well of round-bottom
96-well plates in triplicate. Fifty (50) µl of primary antibodies of anti-CD14 antibody
(clone M-M9; VMRD Inc, Pullman, WA, USA); anti-CD18 antibody (clone BAQ30A;
Kingfisher Biotechnology, St Paul, MN, USA) or anti-L selectin antibody (clone FMC46;
Novus Biological, Littleton, CO, USA) were added to respective wells in triplicates. The
primary antibodies used in staining were pre-diluted 1:100 in PBS containing 1% FBS.
After adding primary antibodies, cells were incubated at 4°C for 10 min followed by 2X
washes with 200 µl PBS containing 1% FBS. After washing, cells were stained with
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FITC-labeled anti-mouse secondary antibody (VMRD Inc., Pullman, WA, USA) with
1:500 dilution in PBS containing 1% FBS at 4°C for 10 min. After secondary antibody
staining, cells were washed again for 2X as described above. Finally, stained cells were
fixed with 200 µl of 1% paraformaldehyde and analyzed by BD Accuri™ C6 Plus Flow
Cytometer (BD Biosciences, CA, USA). The result was recorded as % expression.
Phagocytosis activity of Neutrophils in Response to Infected MDM Supernatant.
The effect of BVDV-infected MDM supernatant on the phagocytic activity of
neutrophils was examined through an E. coli phagocytosis assay kit (Cayman Chemical,
Ann Arbor, MI, USA) according to the manufacturer’ instructions. Briefly, freshly
isolated neutrophils were suspended at a concentration of 106 cells/ml in a culture
medium. Different infected MDM supernatant treatments had been applied to the
corresponding wells in triplicates, including the 3 BVDV strain-specific MDM
supernatants, the mock-treated MDM supernatant, and LPS (2 μg /mL) stimulated
neutrophils as negative and positive controls respectively. One hundred (100) μL of cells
of each sample in triplicate were transferred to a 96-well plate where the cells got mixed
with FITC- labeled inactivated E. coli at a ratio of 1:10. Neutrophils were incubated at
37oC for 1 h. To assess the degree of phagocytosis, cells were centrifuged at 400 x g for 5
min and the supernatant was discarded. After that, the cells were resuspended in 100 μL
of trypan blue to quench the non-specific surface FITC signal. The cells were washed
twice with the assay buffer, supplied with the kit, and resuspended in 200 μL of assay
buffer that will be used for flow cytometry scan using BD Accuri™ C6 Plus Flow
Cytometer (BD Biosciences, CA, USA). The result was recorded as % phagocytosis.
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Neutrophil oxidative burst activity in response to infected MDM supernatant
The effect of BVDV-infected MDM supernatant on neutrophil oxidative burst
activity was examined according to Thakur, 2017 with modification. Briefly, freshly
collected neutrophils were treated with 3 different BVDV infected-MDM supernatants as
well as mocked treated control and incubated for 6 h post-treatment. After that, both
treated or mock-treated neutrophils were washed with PBS and centrifuged at 500 X g for
10 minutes at RT. After washing, neutrophils were resuspended in RPMI 1640 medium
supplemented with 10% FBS, penicillin (100 U /ml), and streptomycin (100 μg /ml) to
achieve a final concentration of 1x106 cells/ml. Neutrophil suspension (200 µl)
suspension from each treatment was then transferred to individual wells in a roundbottom 96-well plate. Mock-treated neutrophils were divided into three groups: 1)
positive control (mock-infected neutrophils treated with oxidative burst inducer phorbol
12-myristate 13-acetate: PMA); 2) negative control (mock-infected neutrophils with no
PMA; and 3) Dihydrorhodamine123 (DHR 123)-negative control/blank [neutrophils with
neither PMA treatment nor DHR 123. The DHR 123-negative control was used to set the
fluorescence gates on the flow cytometer.
Twenty (20) µl of 10 µm DHR 123 (Sigma-Aldrich, St. Louis, MO, USA) was
added to each well, except DHR123 negative control cells. DHR 123 is a colorless dye,
which passively enters the cell and produces fluorescence in the presence of reactive
oxygen species. After adding DHR 123, plates were incubated at 37C for 15 minutes.
Following the incubation, 50µl Phorbol 12-myristate 13-acetate (PMA) 10 nM was added
to each well (except the designated wells for the assay negative control as well as
DHR123-negative control/blank, and the plate was incubated for 15 minutes at 37 C.
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After 15 minutes of incubation, plates were washed with PBS and fixed with 1 %
paraformaldehyde in PBS. The oxidative burst activity in fixed cells was measured using
the BD Accuri™ C6 Plus Flow Cytometer (BD Biosciences, CA, USA) and the result
was recorded in %.
Nitric oxide activity of neutrophils in response to infected MDM supernatant
The effect of BVDV-infected MDM supernatant on nitic oxide activity of
neutrophils was examined using the Griess Reagent. Briefly, freshly collected neutrophils
were treated with 3 BVDV strain-specific MDM supernatants as well as mocked treated
control and incubated for 6 h at 37°C. Cell samples from each treatment were then
stimulated with LPS (25 µg/mL) (Sigma, St. Louis, MO, USA) for 1 h. Then,
supernatants were collected and nitric oxide (NO) concentration was determined using
Griess reagent (Sigma, St. Louis, MO, USA) using Nitrite (NO2) measurement as an
indicator of NO production according to the protocol of Blond et al., 2000: briefly, in
each well of a 96-well plate, a 100 µL of culture supernatant was added to 100 µL of
Griess reagent, that was made of a 1:1 mixture of 1% sulfanilamide and 0.5% N-(1naphthyl) ethylenediamine dihydrochloride (Sigma, St. Louis, MO, USA) in 30% acetic
acid. Reactions were performed in triplicate at RT for 10 min. Absorbance was then
measured at 540 nm in a microplate reader (Biotek, ELx808, Winooski, VT). Nitrite
concentration was evaluated by plotting the average OD values of each sample (in
triplicates) against sodium nitrite standard curve (Sigma, St. Louis, MO, USA) with a
detection range of 1.95-200 μmol/ml.
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Neutrophil extracellular traps (NETs) formation in response to infected MDM
supernatant
NETS are networks of extracellular fibers, primarily composed of DNA
from neutrophils. Upon in vitro stimulation with PMA, neutrophils release
granule proteins and chromatin to form an extracellular fibril matrix known as NETs.
These NETs can be measured through the quantification of extracellular DNA released in
the active process. Quant-iT™ PicoGreen™ dsDNA Assay Kit (Thermo Fisher
Scientific, Waltham, MA, USA) was used to measure the extracellular DNA released in
the supernatant after being separated from the network with the aid of micrococcal
nucleases (New England Biolabs, Ipswich, MA, USA) followed by staining with an
asymmetrical cyanine dye, a free dye that doesn’t fluoresce, but upon binding to dsDNA
it exhibits a >1000-fold fluorescence enhancement. To measure the effect of infected
MDM supernatant on neutrophil extracellular traps (NETs) formation, a neutrophil
sample from each treatment group, including the 3 BVDV strain-specific MDM
supernatants and the mock-treated control were pelleted 6 h post-treatment and adjusted
to 5 x 105/ml and washed twice with PBS before being submitted for PicoGreen assay
according to manufacturer’s instructions. Briefly, the neutrophil samples (in triplicates)
were incubated with 20 nM PMA to stimulate NET formation for 4-5h. Then, the
neutrophils were pelleted at 250 Xg for 3 minutes and the supernatant was discarded.
Micrococcal nuclease (New England Biolabs, Ipswich, MA, USA) 0.1 U/ μL, in
micrococcal nuclease buffer, was added to each sample pellet and incubated for 15 min at
37oC. One μL of each sample was added to 99μL of 1X TE buffer, supplied in the kit, in
the microplate well and mixed by pipetting up and down. A lambda DNA standard was
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prepared with a range of 5-2000 ng/ml in duplicates for measuring the NET formation
level in each sample by plotting the sample values against the standard curve values. An
equal volume (100 μL) of diluted PicoGreen 1/400 in TE buffer was added to the volume
of each standard and sample and mixed by pipetting up and down. The microplate was
covered with foil and incubated at RT for 2-5 minutes. The plate was read at excitation of
485nm/20nm and emission of 530nm/25nm wavelength/bandwidth. Another mocktreated-non-PMA-stimulated was included to convert the level of NET formation into %
through the following equation:
(Amount of extracellular DNA in PMA-stimulated treatment - Amount of extracellular
DNA in non-stimulated mock-treatment) / Amount of extracellular DNA in PMA
stimulated mock-treatment - Amount of extracellular DNA in non-stimulated mocktreatment) x 100.
Statistical analysis
Data were analyzed using a paired t-test at a 5% level of significance (Microsoft
EXCEL, MAC 2011) to assess the significance of the differences between mean values of
treated and control samples at each time point. Every experiment was achieved using at
least 3 animals (biological replicates) conducted 3 times each (technical replicates) to
confirm the reproducibility of the methods used. The variations in results were calculated
by standard deviation at each time point (Glantz, 2002).
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RESULTS
The role of secreted viral proteins in MDM mediated lymphocyte apoptosis
To determine role of the secreted viral protein in BVDV-infected MDM
supernatant on bovine lymphocyte apoptosis, immunoprecipitation of viral proteins was
performed on supernatant, and the viral protein-depleted-infected MDM supernatants (IP
supernatants) was applied to fresh lymphocyte culture in contrast to the initial BVDVinfected MDM supernatants. This was followed by Annexin V testing of lymphocyte
apoptosis. No significant difference between immune-precipitated MDM IP supernatants
(296C IP supernatant: 32.8% & 1373 IP supernatant: 36.7%) and the initial ones (296C
supernatant: 31.5% & 1373 supernatant: 37.2%) for both 296C and 1373 strain. Cp 296Cinfected lymphocyte that was used as a BVDV apoptosis control showed adequate
apoptotic response with 38.4% apoptosis. STS control had 73.4% lymphocyte apoptosis
whereas the mock-treated supernatant had 13.3 % of lymphocyte apoptosis. (Figure 2.1.).
Pro-inflammatory cytokine level in infected MDM supernatants or LPS treated control
The level of apoptosis-related-inflammatory cytokines TNF-alpha and IL-1beta
were measured in the supernatant of the infected MDM with 296C and 1373 to rule out
their role in the induction of lymphocyte apoptosis. Both 1373 and 296C infected MDM
supernatants had no detectable levels of TNF-alpha and IL-1beta. LPS positive control
had 158.7 pg/ml of TNF-alpha and 226.4 pg/ml of IL-1beta, whereas the mock-treated
control had non-detectable levels of either cytokine (Figure 2.2.).
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Effect of BVDV-infected MDM supernatant on neutrophil viability
To measure the viability of neutrophils in response to different treatments and
control, CyQUANT™ LDH Cytotoxicity Assay Kit, as well as trypan blue exclusion test,
were used to test each treatment in triplicate at 4 different time points (0-6h) posttreatment. Methanol-treated neutrophils were included as a positive cell death control
while mock-treated neutrophils serve as negative control against which the treatments
were contrasted. There was no significant difference in % viability of neutrophils among
groups in contrast to the mock-treated control. 296C supernatant had a range of 82.393.7%, while 1373 supernatant had a range of 82.5-93.2% and 28508-5 viability ranged
from 82.9-93.4 at 6h compared to 83.8-93.7% viability for Mock-treated control. The
methanol positive control had 100% cell death by 3h post-treatment.
Effect of BVDV-infected MDM supernatant on neutrophil surface marker expression
To measure the changes in surface marker expression in response to BVDVinfected MDM supernatants 6 post-treatment, indirect IF combined with flow analysis
was used. All BVDV supernatant downregulated CD18 at 6 h post-treatment whereas
296c, 1373 and 28508 supernatants reduced it by 11.8%, 10.2%, and 7.6% respectively.
However, it was a non-significant downregulation (p = 0.088) for all BVDV
supernatants. In contrast, LPS-treated control had a significant up-regulation (p<0.05)
with a 13.8% increase in CD18 expression, compared to the mock-treated control (Figure
2.4.).
All BVDV supernatants significantly (p<0.05) down-regulated the expression of
L-selection on the surface of the treated neutrophils compared to the mock-treated control
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at 6 h post-treatment. Treatment of neutrophils with 296c, 1373, or 28508 supernatants
reduced L-selectin expression by 14.1%, 20.6%, and 18.2% respectively. LPS-treated
controls also down-regulated L-selection expression on the surface of treated neutrophils
by 23.9% compared to the mock-treated control in a significant way (p<0.05) (Figure
2.4.). CD14 expression was low on the surface of neutrophils in all viral supernatant
groups and was not affected 6 h post-treatment while the LPS-treated positive control
group had a significant up-regulation of CD14 expression (data not shown).
Effect of BVDV-infected MDM supernatant on neutrophil phagocytic activity
The phagocytic capability of neutrophils was evaluated in response to different
BVDV-infected MDM supernatants by using FITC-labeled E. coli combined with flow
analysis. All BVDV supernatants did not affect the phagocytosis ability of neutrophils at
6 h post-treatment compared to the mock-treated control. Treatment of neutrophils with
296c, 1373, or 28508 supernatants resulted in 55.1%, 54.1%, and 55.4% phagocytosis
respectively compared to 58% for mock-treated control (Figure 2.5.) This has been
repeated 3 times and there was no significant difference between the groups (p = 0.14)
(Figure 2.6.).
Effect of BVDV-infected MDM supernatant on neutrophil oxidative burst
To measure neutrophil oxidative burst activity in response to different BVDVinfected MDM supernatants, neutrophils were stimulated with PMA after treatments
followed by applying DHR stain to the stimulated cells and flow analysis. The activity
was measured 6 h post-treatment and neutrophils treated with 296c, 1373 or 28508
supernatants had 41.6%, 43.3%, and 47.9% oxidative burst activity compared to 50.3% in
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the mock-treated positive control. There was no significant difference between groups (p
> 0.05) (Figure 2.7.).
Effect of BVDV-infected MDM supernatant on neutrophil nitric oxide (NO) activity
To measure neutrophil nitric oxide production in response to different BVDVinfected MDM supernatants, neutrophils were stimulated with LPS after treatments
followed by Griess reagent to the stimulated cells. The nitric oxide production was
measured 6 h post-treatment. Neutrophils treated with 296c, 1373 or 28508 supernatants
produced 78.8, 117.3, and 119.8 µmol/mL of NO respectively compared to 127.6
µmol/mL of NO in mock-treated control. Only the Cp 296c supernatant significantly (p<
0.05) down-regulated nitric oxide production in LPS stimulated neutrophil in comparison
to the mock-treated LPS-stimulated control while the Ncp supernatant didn’t show
significant difference from the mock-treated group (p>0.05) (Figure 2.8.).
Effect of BVDV-infected MDM supernatant on neutrophil extracellular trap (NET)
formation
To measure NET formation by neutrophils in response to different BVDVinfected MDM supernatants, neutrophils were stimulated with PMA after each specific
treatment followed by applying micrococcal nuclease to release the extracellular DNA
from cells undergoing NET formation, The amount of extracellular DNA was measured
with the aid of PicoGreen kit, and the result was read and analyzed by fluorometer as
described in the methods section. The %NET formation was measured 6 h post-treatment.
Neutrophils treated with 296c, 1373, or 28508 supernatants showed 81.4%, 97.6%, and
98.2% NET formation respectively compared to 100% in mock-treated control. Only the
Cp 296c supernatant significantly (p< 0.05) down-regulated NET formation in PMA
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stimulated neutrophils, while the Ncp supernatants didn’t show significant difference
from the mock-treated PMA stimulated group (p>0.05) (Figure 2.9.).
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DISCUSSION
This study demonstrated a key role of macrophages in BVDV immune
dysfunction. In this study, the effect of BVDV-infected MDM supernatants on neutrophil
viability, surface marker expression, and functional activity was evaluated. None of the
infected MDM supernatants had a significant effect on neutrophil viability up to 6 h posttreatment compared to the mock-treated control. Our findings are inconsistent with the
findings reported by (Thakur 2017), as neither the TGAN nor TGAC strain of BVDV
affects the neutrophil viability. Other studies reported observable neutropenia or had
impaired neutrophil activity in vivo following BVDV infection (Brown et al., 1991; Roth
et al., 1981). However, this finding has been reported in vivo, which is quite a different
environment than in vitro. This result could be due to a direct effect on hematopoietic
production, it could also be due to cell margination or other hemodynamic mechanisms
that may affect the count of neutrophils in the blood.
This study demonstrated that the infected MDM supernatants downregulated the
expression of CD18 compared to the mock-treated control, however, the difference was
not significant (p =0.088). On the other hand, all the supernatants significantly downregulated L-selectin expression on the surface of neutrophils compared to the mocktreated control at 6 h post-treatment (p< 0.05). CD18 and L- selectin are 2 important
surface markers that regulates neutrophil adhesion, rolling, diapedesis, and signal
trafficking to the site of local injury. Impairment of their expression will affect the net
functional activity of neutrophils (Walzog et al., 1999, Kolaczkowska and Kubes, 2013).
CD18 is important for the maturation and release of neutrophils to the circulation in vivo,
while L-selectin help in margination and receptor mediated homing (Gomez and
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Doerschuk, 2010). This suggested that the downregulation of CD18 and L-selectin in vivo
can lead to neutropenia (Yoshitake et al., 2002), and this may explain the findings of
(Roth et al., 1981). In a previous work, both L-selectin and CD18 were downregulated in
response to direct infection of neutrophils with BVDV strains, that was linked with
significant negative impact on normal neutrophil functional activity, especially migration
(Thakur et al., 2020; Al-Kubati et al., 2021). Additionally, CD14 expression was also
evaluated in the current study; however, its initial expression was low on the mock
treated neutrophil (< 13% at 0 h) and none of the treatment significantly changed this
percentage at 6 h post treatment. CD14 is recognizes endotoxin on invading gramnegative bacteria as well as its co-operative role with TLR-4 in phagocytosis. High
virulent 1373 MDM supernatant has significantly downregulated the expression of CD14
but not the low virulent supernatants as early as 12 h post-treatment. CD14
downregulation was also associated with the reduction in the phagocytic activity of
macrophage in the same study (Abdelsalam et al., 2020) and of neutrophils in hepatitis C
virus (HCV) patients (Jirillo et al., 1995).
The functional activity of neutrophils in response to different BVDV-infected
MDM supernatants has been evaluated. Phagocytosis is one of many defense mechanisms
that is used by phagocytes to defend against microbial invasion. Phagocytosis is
considered a link between innate and adaptive immune response as successful phagocytic
activity leads to successful antigen presentation and thus good initiation of the adaptive
immune response. In this study, none of the MDM supernatants affected the phagocytic
activity of neutrophils at 6 h post-treatment compared to the mock-treated control
(p=0.14). A previous study reported that neutrophils isolated from Cp BVDV-infected
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animals had a decrease in paraffin oil uptake in contrast to neutrophils isolated from
noninfected control (Roth et al., 1981). (Abdelsalam et al., 2020) has reported the effect
of BVDV-infected MDM supernatants on macrophage phagocytic activity Compared to
the direct BVDV infection of macrophages. It was reported that only virulent BVDV or
its corresponding infected MDM supernatants significantly inhibit the phagocytic activity
of treated MDM compared to the mock-treated control. This inhibitory effect was as early
as 12h post-infection with virulent 1373 strain and at 24 h post-treatment with 1373MDM supernatants. Our finding was at 6 h post-treatment that could be too early for the
MDM supernatants to show their effect. Unlike our finding, previous research has
reported that Cp BVDV strains only was able to reduce neutrophil phagocytic activity
(Thakur et al., 2020; Al-Kubati et al., 2021). The difference could be either due to the use
of different strains as in (Al-Kubati et al., 2021) or the fact that our finding is based on
the effect of infected MDM supernatant rather than direct infection with the virus.
Our study also demonstrated a reduction in the oxidative burst activity of
neutrophils in response to different BVDV-infected MDM supernatants at 6 h posttreatment. All infected MDM supernatants non significantly reduced the oxidative burst
activity of PMA-stimulated neutrophils compared to the mock treated PMA-stimulated
control (p> 0.05). Our results showed that the most downregulation happened in response
to Cp 296c MDM supernatant with a 7.2% decrease compared to the mock-treated
control. A previous study showed the oxidative burst activity in response to BVDV direct
infection of neutrophils where oxidative burst activity has been downregulated in
response to the 4 strains of BVDV, regardless of their virulence nor biotype at 6 h postinfection (Thakur, 2017). The difference between this finding and ours could be because
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we tested the infected MDM supernatants rather than directly infecting neutrophils with
BVDV virus strains. Inhibition of neutrophil functional activity following BVDV
infection has also been reported in other studies that have been conducted on neutrophils
isolated from vaccinated animals with modified live singer Cp BVDV strain (Roth and
Kaeberle, 1983).
The nitric oxide production of LPS-stimulated neutrophils has been evaluated in
response to different BVDV-infected MDM supernatants at 6h post treatment compared
to the mock-treated group. Only Cp BVDV supernatant significantly reduced nitric oxide
production in the stimulated neutrophils. Cp 296c supernatant reduced nitric oxide
production more than 37% reduction compared to the mock-treated controls. The NCP
supernatants had less than 7% reduction compared to the mock-treated controls. ROS and
NO production are the 2 major mechanisms by which the phagocytosed pathogen will be
destroyed. Our data was similar to that reported by Elmowalid, 2003 where only
supernatant from MDM infected with Cp strain up-regulated NO production in the LPSstimulated MDM. Our data also similar with what was reported by Abdelsalam et al.,
2020 about the Ncp MDM supernatants that didn’t significantly affect NO production
compared to mock-LPS stimulated control at 12-24h post-treatment. Other studies
showed that infection with HCV, another flavivirus, upregulated NO production in mice
livers (Lasarte et al., 2003).
This study also tested the ability of PMA-stimulated neutrophils to undergo NET
formation in response to treatment with different BVDV-infected MDM supernatants at
6h post-treatment compared to the mock-treated-PMA stimulated control. Only Cp
MDM supernatant significantly downregulated NET formation by 18.6% (p < 0.05) from
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the mock-treated PMA stimulated control. On the other hand, less than 3% inhibition was
reported in the case of Ncp MDM supernatants. Thakur et al., 2020 demonstrated that the
infection of neutrophils with BVDV led to significant up-regulation in NET formation,
regardless of their virulence nor biotypes. The difference between this finding and ours
could be due to many reasons that include, but are not limited to, the different design of
the experiment where we examine the effect of the infected MDM supernatants rather
than BVDV direct infection of neutrophils. Another difference could be the way that we
measure the NET formation is based on the detection of the extracellular DNA while in
Thakur et al. examined the presence of extracellular elastases. Also, the original
hypothesis and analysis could be another reason for the observed variation, as we
examined the impact of the infected supernatants on the NET formation from the PMAstimulated neutrophils while Thakur et al., examined the ability of BVDV infection of
neutrophils in inducing NET formation and they had PMA as a positive control.
In a previous study conducted in our lab, we reported that the high virulent
BVDV-infected MDM supernatant was able to induce lymphocyte apoptosis in vitro as
early as 24h post-treatment. The mechanism by which this supernatant exerts lymphocyte
apoptosis is not characterized yet (Abdelsalam et al., 2020). Previous studies reported the
involvement of different factors and mediators, of viral and cellular origin, in the
pathogenesis and outcome of BVDV infection (Janeway et al., 2001; Jensen et al., 1991;
Darweesh et al., 2018 Markham et al., 1985; Van Reeth et al., 1997; Welsh et al., 1995).
In the current study, we investigated soluble factors that induced apoptosis in
BVDV-infected MDM supernatants. Previous work suggested the involvement of Erns
glycoprotein as a soluble factor that can induce lymphocyte apoptosis in CSFV (Bruschke
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et al., 1997) We have tried to exclude the possible role of soluble viral proteins in the
supernatant that initiate lymphocyte apoptosis. We have immune depleted using
immunoprecipitation these possible viral proteins from the supernatant, and we re-tested
supernatant’s ability to induce lymphocyte apoptosis. Our data suggested that soluble
viral proteins are not involved in inducing lymphocyte apoptosis. We sought to examine
other cellular immune factors that may be present in the apoptotic-inducing supernatant.
We were unable to detect apoptosis-related cytokines. TNF-alpha or IL-1 beta using a
sensitive ELISA detection kit (pg/ml level). This further suggests that these cytokines are
not involved in the induction of lymphocyte apoptosis. Our findings were different from
those reported in for CSFV where TNF-alpha was involved in the process of triggering
lymphocyte apoptosis (Choi et al., 2004) However .our work was consistent with a
previous BVDV work that excluded the role of pro-inflammatory cytokines in the
induction of lymphocyte apoptosis in vitro (Pedrera et al., 2009). Recently, we submitted
the infected MDM lysate of the different groups for Mass Spec analysis, and are currently
waiting for the results.
In conclusion, our data supported the role of the macrophage as a key component
in the immunopathogenesis of BVDV infection. Our results provide a possible
explanation for the immune dysfunction that is associated with BVDV infection and seen
as lymphoid depletion and secondary bacterial infection in the field. Further future
studies need to be conducted to identify the nature of these soluble factors and the
mechanism by which they induced lymphocyte apoptosis.
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Figure 2.1. The role of soluble viral protein in lymphocyte apoptosis: Measurement of
lymphocyte apoptosis % in immune-precipitated-infected MDM supernatant (IP sup) or
regular infected MDM supernatants (296C sup and 1373 sup) at 36 h post-treatment
compared to staurosporine apoptosis-positive control or mock-treated (cells + media
only) control. n=3
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Figure 2.2. The level of apoptosis-related-cytokines (TNF-alpha and IL-1beta) in
different BVDV-infected MDM supernatants (296 C and 1373 sup), or LPS treated
control at 36 h post-treatment compared to the mock-treated (sup of non-infected MDM).
n=3
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the experiment for the main treatments

70
60
50
40
30
20
10
0
0
296C sup
Methanol (positive control)

1

3

Time points (h post treatment)
1373 sup

6
28508-5 sup

Mock-treated control

Figure 2.3. The effect of BVDV-infected MDM supernatants on neutrophil viability: %
Viability of neutrophils in response to treatment with BVDV infected MDM supernatant
(296C and 1373 sup) or methanol-treated death control in contrast to mock-treated (cells
+ medium only) control. The result is the average of at least 3 replicates n=3.
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Figure 2.4. The effect of BVDV-infected MDM supernatants (296C, 1373, and 28508-5
sup) on neutrophil surface marker expression: (A) CD18, (B) L-selectin, and (C) CD14.
Sup: supernatant*: p < 0.05 (>95% confidence). The result is the average of at least 3
replicates (n=3).
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Figure 2.5. The effect of BVDV-infected MDM supernatants (296C, 1373, and 28508-5
sup) on neutrophil phagocytic capability (%) in contrast to mock-treated (non-treated
normal neutrophils engulfing bacteria) control using BD Accuri™ C6 Plus Flow
Cytometer. (A) Mock-treated control, (B) 28505-5 Sup, (C) 1373 Sup, and (D) 296c Sup.
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Figure 2.6. The average phagocytic activity (MFI) of neutrophils in response to treatment
with different BVDV-infected MDM supernatants (296C, 1373, and 28508-5 sup)
compared to the mock-treated (non-treated normal neutrophils engulfing bacteria)
control. The result is the average of at least 3 replicates (n=3).
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Figure 2.7. The effect of BVDV-infected MDM supernatants (296C, 1373, and 28508-5
sup) on PMA-stimulated neutrophils’ oxidative burst activity compared to the mocktreated stimulated (non-treated, PMA stimulated) control. Sup: supernatant (p>0.05). The
result is the average of at least 3 replicates (n=3).
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Figure 2.8. The effect of BVDV-infected MDM supernatants on neutrophil nitric oxide
production 6 h post-treatment compared to the mock-treated control. *: significant (p <
0.05) Sup: supernatant. The result is the average of at least 3 replicates.
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Figure 2.9. The effect of BVDV-infected MDM supernatants (296c, 1373, and 28508-5
sup) on induction of NET formation in PMA-stimulated neutrophils 6 h post-treatment
compared to the mock-treated, PMA-stimulated control. *: significant (p < 0.05) Sup:
supernatant. The result is the average of at least 3 replicates.
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Table 2.1. Different strains of BVDV used in the current study.

BVDV strains

Biotype and

Virulence

Titer

Genotype
1373

Ncp, BVDV-2

High virulence

5.8E+05

28508-5

Ncp, BVDV-2

Low virulence

7.2E+06

296C

Cp, BVDV-2

Virulent

5.2E+05

93

CHAPTER 3
NOVELITY IN BVDV-RESEARCH: I- STUDYING THE TROPHISM OF BVDV
AND BOSAVIRUS IN THE AMERICAN BISON. II- EXAMINING THE
SUSCEPTIBILITY OF NEW PRIMARY CELLS AGAINST BVDV AND OTHER
BRD-RELATED VIRAL PATHOGENS
ABSTRACT
Bovine Viral Diarrhea Virus is the leading endemic infection in US cattle
industry. BVDV is responsible for different respiratory and reproductive syndromes in
cattle in the US despite the current vaccination program. Although cattle are the main
reservoir for BVDV, a broad spectrum of other small and large ruminants are susceptible
to infection and disease including the American bison, that are in free-range or in captive
herds. Many bison samples from many herds have been submitted to the Animal Disease
Research and Diagnostic Laboratory at South Dakota State University, Brookings, SD.
Upon testing, bison have been found to be positive for BVDV in the whole blood and or
nasal swab samples. In this chapter, we will discuss an in-depth investigation of one of
these bison cases. The trophism of BVDV and its co-existence with the novel Bosavirus,
a Copiparvo ss DNA virus, in different tissue of American bison was investigated. Tissue
samples from several different tissues were collected from 4 different animals, the
nucleic acid was extracted and the viral nucleic acid in these tissues quantified by qPCR
assay. Two of 4 animals were positive for each virus; one animal was BVDV and
Bosavirus-infected, another animal was BVDV-infected, Bosavirus-free, another animal
was BVDV-free, Bosavirus-infected and the last animal was BVDV and Bosavirus-free.
Interestingly, the BVDV and Bosavirus viral nucleic acid was higher in the animal that
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was free for the other virus while the animal that was both BVDV and Bosavirus-infected
had lower viral load for both viruses. Both Bosavirus and BVDV were in all tissue with
the highest viral copies detected in small intestine for Bosavirus which was the tissue
with the lowest viral load for BVDV. BVDV was detected multiple tissues including skin
suggesting that the infected animals could be PIs. Comparing between the viral load in
our study cases (American bison PI) and that of cattle PI reported in a previous study,
revealed that the viral load of BVDV in the skin of cattle PI is higher than that of the
American bison and the vice versa for the internal organs, where bison had more viral
loads. Studying BVDV in vitro has many advantages, but never as accurate as in an in
vivo study. While we conduct most of BVDV research in vitro using established cell
lines, a primary cell system may be required to provide more realistic and reliable data
that more closely reflects the cell types infected in vivo in the animal. In the second half
of this chapter, we sought to test the susceptibility of primary bovine tracheal cells to
BRD-related viral pathogen in vitro. The primary tracheal cells were permissive to BHVI, Cp BVDV-I, Cp BVDV-II and Ncp BVDV-II. There was no difference in the virus
growth kinetics for the BHV-I, Cp BVDV-I, Cp BVDV-II viruses on the primary
tracheal compared to the susceptible BT cell-line. The Ncp BVDV grew signifacnatly
better in in the BT cells than the primary tracheal cells at 48-h pi. The level of type I IFN
was also measure in the primary tracheal cells compared to the BT cell-line in response to
the infection with the 4 BRD-related viral pathogens. There was no significant difference
in response between the 2 cell types, however all 3 cytopathic strains managed to
upregulate type-I IFN response, while Ncp BVDV blocked its expression in both type of
cells.
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INTRODUCTION
BVDV has a wide range of hosts as BVDV infection has been reported in both
domesticated and wildlife with a remarkable high infection rate for wildlife that
frequently interact with through common range or agricultural interfaces. BVDV has
been isolated in other species than cattle that includes, but not limited to sheep, goat,
pigs, antelope, deer and bison (Nelson et al., 2016; Wolff et al., 2016; Van Campen and
Rhyan, 2010). The wildlife BVDV isolates are indistinguishable from bovine isolates and
can infect cattle with the typical forms of BVDV infection and mild clinical signs (Deregt
et al., 2005). Bison are infected with both BVDV-I and BVDV-II with a wide range of
symptoms that included mucosal and peracute disease. The infection in bison, like cattle,
can be vertical or horizontal and the risk of developing a persistently infected animal is
possible (Deredet et al., 2005; Hause et al., 2021). The two main factors believed to favor
the spread of infection in bison are the presence of persistently infected (PI) animal and
being in close proximity to a cattle herd (Hause et al., 2021).
Persistently infected (PI) cattle are the main reason BVDV is endemic in the US
despite the current vaccination program (Ridpath, 2012). PI is established when Ncp
BVD is transmitted vertically from the infected dam to the fetus at the earlier stage of
gestation, 30-110 days which is before the development of fetal immune system at ~150
days (Figure 3.8.) (Brownlie et al., 1990; Ridpath, 2012; Schweizer et al., 2006). Unlike
Cp BVDV, the Ncp strain doesn’t result in early embryonic death. It was suggested that
the blocking of the innate immune system achieved by Ncp BVDV infection, including
IFN inhibition is a very important step towards establishing PI, since IFN are very
important in activating the adaptive immune response that would clear the virus from the
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body (Peterhans et al., 2003). In PI animals, the virus will replicate continuously since
there is no defense mechanism that prevents its spread, a condition known as
immunotolerance (Chase et al., 2004; Larsson and Fossum, 1992). BVDV replication
occurs throughout the body and the virus is present in all secretions making the PI animal
a threat to the whole herd. An important and rapid test for PI is the ear notch detection of
virus in the suspected animal.
Bosavirus is a novel parvovirus that was first identified as a cell culture
contaminant in pooled fetal bovine serum with the aid of metagenomic analysis (Sadeghi
et al., 2017). It is a small, single stranded, non-enveloped DNA virus with a short 5-6 kb
genome. Its genome contains two open reading frames (ORFs) that encodes for
nonstructural proteins that help in virus replication and capsid formation. Bosa virus is
classified under family, Parvoviridae, that contains 2 subfamilies: Parvovirinae infecting
vertebrates and the Desovirinae that infect arthropods. The Parvovirinae contain eight
different genera (Liet al., 2015; Sadeghi et al., 2017; de Souza et al., 2018). Out of these
8 genera, Bosavirus has been classified under genus Copiparvovirus together with 6 other
species (total of 7 species). Out of these seven species, two were identified in cattle
(Ungulate copiparvovirus 1 and 5) (Figure 3.9.). Copiparvovirus genus, is closely related
to bovine parvovirus 2 (BPV2); as it is found to be identical with 41% identity to the nonstructural protein NS1 and with 47% identity to the virus capsid protein of BPV2
(Cotmore et al., 2019). Bosavirus was identified in a BVDV persistently infected cattle
during the investigation of the bovine virome (Weber et al., 2018). A Bosavirus has been
recently identified in American bison (bison bosavirus) and was closely related to bovine
bosavirus that formed a sister clade together to place bison bosavirus under
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copiparvovirus genus (Hause et al., 2021). The etiological significance of most
Copiparvoviruses is still unknown and further work need to be done to reveal their
significance.

Primary cell culture is obtained directly from parental tissue, in contrast to cell
line that is a modified descendant of the primary cell culture, which is generally used to
expand cell population and prolong life span. Each culture system has some advantage
and disadvantages. Primary cell system is biologically relevant as it closely resembles the
primary cell of origin with minimal mutations that make it quite similar to the original
tissue, unlike a cell line that may have developed somatic changes to adapt to in vitro
growth conditions. In addition, undifferentiated fibroblasts that are a common “cell
contaminate” from primary cells may outgrow the “target cell” so that the “cell lines” are
mainly fibroblasts. All these factors may make cell lines not “representative” of the
original tissue. Primary cells cannot be passaged and subcultured over a long period of
time as these cells have a finite number of cell cycles after which they can’t divide and
grow so it is hard to keep one good source for long time. Obtaining “pure” primary cells
is a multi-step, laborious with high risk of microbial contamination, and over time usually
end up with a “mixed” culture (i.e., fibroblasts) rather than a single population of cells.
Another advantage of using primary cells over cell-line is the opportunity to study and
investigate in vitro response of donors in the development of new drugs and
pharmaceutical products. It is important to use primary cells for investigation of certain
biological process in vitro to get a more “realistic” data but when it comes to routine
work probably early passages of a cell line suffice (Butler et al., 2004; Berg et al., 2002).
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The current study aimed to investigate the transmission of BVDV in vivo or in
vitro. The main objectives of this study are to:
1. Investigating the trophism of BVDV in different tissue of the American Bison and
its co-existence with Bosavirus.
2. Examining the susceptibility of a new primary cell line to BVDV and other BRDrelated pathogens.
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MATERIAL AND METHODS
Animal
Tissues from four American bison were submitted to the ADRDL, SDSU after being
separated from a private herd in Nebraska due to unthriftiness. ADRDL numbers were
assigned to each animal with a short description (Table 3.1). A variety of tissues has been
submitted for each animal (Table 3.1).
Viruses and templates

Singer strain of BVDV which is a Cp BVDV1a, has been used to create a
standard curve against which the CT values of different samples will be plotted to
calculate their TCID50 equivalent/ml. The standard curve has been created out of 10-fold
serial dilution to a stock singer strain at 1.5 x 106 TCID50/mL. The primers and probes
used to target the 5′ untranslated region (5′UTR) of BVDV viral genome (Table 3.2).

Since there is no isolation method nor culture system for Bosavirus, a DNA
template was designed according to the primers and probe used by (Hause et al., 2021)
that target the capsid protein of strain 20-8536 (Table 3.2).

Nucleic acid extraction

Different tissues from each animal were cut into smaller pieces and homogenized
by squeezing using syringe. 1mg (in triplicate for each tissue = 3 mg total for each tissue)
of tissue homogenate was applied for nucleic acid extraction. In case of BVDV, viral
RNA was extracted using spin-column based viral RNA extraction kit while in case of
Bosavirus, a spin column-based DNA extraction kit was used (Qiagen, Venlo,
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Netherlands). Both kits are Triazole-based extraction kit with no organic extraction and
the principle and procedures are quite similar and. Briefly, the tissue homogenate was
allowed to lyse in the kit lysis buffer. In case of viral RNA extraction, carrier RNA was
added to the lysis buffer to increase the yield by enhance to binding of the nucleic acid to
the membrane and inactivate possible RNase contaminant. In case of viral DNA
extraction, proteinase K was added to complete the lysis process. The sample is vortexed
and incubated with the lysis buffer for 10 at RT. Same volume of 96% ethanol was added
to the lysate and the mix was transferred to the RNA/DNA spin column. The spin
columns were centrifuged at 8000 Xg for 30 sec, and the filtrate was discarded. Two
different wash buffers were added successively with centrifugation in between at 8000 x
for 30 second and discarding the filtrate. Washing is important to remove impurities like
divalent cations and proteins that may inhibit the down-stream application Eventually the
pure viral RNA/DNA, that is attached to the membrane is eluted in 50 µL of RNaseDNase free water. The extracted nucleic acid of each sample was submitted for
quantification by nanodrop ND1000 (Thermo Fisher Scientific, PA, USA) and at least
5ng/ul was used for qPCR.

Standard curve

For BVDV, the Singer strain was used at a stock concentration of almost 1.5 x
106. The stock virus was extracted, and the eluted RNA was diluted in a 10-fold dilution
manner. For Bosavirus the template DNA was quantitated by nanodrop ND1000 (Thermo
Fisher Scientific, PA, USA) and was diluted to create the following concentrations: 200,
100, 50, 25, 10, 5 and 1 ng/ul. The following equation was used to calculate the copy
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number for each standard: Weight (ng) x Avogadro constant (6.022 x 1023)/length (bp) x
109 x nucleotide mass (660). These different dilutions of each virus extracted RNA/DNA
template were submitted for q PCR to build a standard curve, and the resulting Ct values
were plotted against their initial TCID50 or copy number. The equation attached with the
logarithmic plot for each virus was used to covert the CT values of the samples into DNA
copy number or TCI50 equivalent/mL as shown in (Figure 3.1).

Quantitative polymerase chain reaction (qPCR)

Around 5 ng of each sample were used to run the qPCR using TaqMan Fast
Advanced Master Mix (Thermo Fisher Scientific, PA, USA) in a 25 ul reaction according
to the manufacturer’s instructions. The amplification parameters included 50o C for 10
minutes for reverse transcription (in case of BVDV), This step is skipped in case of
Bosavirus samples. This was followed by initial denaturation at 95o C for 10 min then, 40
cycles denaturation at 95o C for 15 seconds, annealing and extension at 60o C for 60
seconds. The result was reported as triplicate Ct values for each sample and the average
was plotted against the corresponding standard curve to convert the CT values into
TCID50 equivalent (in case of BVDV) or copy number (in case of Bosavirus).

Cells and viruses

Primary bovine tracheal epithelial cell (kindly provided by Dr. Kaushik) was used
to examine its susceptibility against three BRD-associated viral pathogen; BHV-1
(cooper), BVDV I (Singer) and BVDV II (Cp A125 and Ncp 1373). All strains were
previously titrated, and their titer was recorded in the virus logbook. Bos taurus turbinate
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cell-line (BT, P:76-78) was used as a reference susceptible cell line to which the
performance of the primary cells was to be compared.

Cell culture and infection
The primary tracheal cells, Passage (3-5) were grown in a complete medium of
Dulbecco minimum essential medium (DMEM), diluted 1:1 with F12 ham nutrient mix
(Gibco BRL, Grand Island, NY), supplemented with 10% BVDV-free fetal bovine serum
(FBS) (Hyclone Laboratories, Logan, UT), 1X insulin-transferrin-selenium (ITS), 5
ng/mL epidermal growth factor (EGF) ( (Sigma-Aldrich, St. Louis, MO, USA) penicillin
(100 U /ml) and streptomycin (100 μg/ml). The cells were maintained at 37°C with 5%
CO2 in the humidified incubator and were split once the sheet reached 70-90%
confluency, usually in 3 days. The tracheal cells were plated into 96-well plate ready for
infection with the 3 BRD viral pathogens. 300 TCID50 of cooper strain of BHV-1, Singer
strain of BVDV I, A125 strain of BVDV II, or 1373 strain of BVD II were used to infect
separate well of the primary tracheal cells (at least one raw per virus strain). The infected
cells were incubated for 1 h with each virus and then washed to remove the excess
unbound virus and 200 µl of complete medium was added to each well. The cells were
either observed for CPE for 3 days of incubation or stained in case of the Ncp virus. On
the 3rd day, the cells infected with Ncp 1373 of BVDV were fixed in 20% acetone for 30
min followed by staining with FITC-conjugated anti-BVDV polyclonal antiserum
(VMRD, Pullman, WA, USA) in a direct FA assay. The stained cells were incubated for
1 h at 37°C followed by washing with PBS 3 times to remove excess stain. The virus
infection was investigated using fluorescent microscopy (Olympus, PA, USA).
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Virus growth kinetics
Virus growth was evaluated in the supernatant of the infected primary tracheal
cells at different time points for 48 h post infection. Briefly a confluent sheet of primary
tracheal cells was disaggregated and plated into a 96 well plate. Once the sheet was 70%
confluent, 300 TCID50 of each virus strain were added in a virus maintenance medium
containing 2% FBS, and 1x antibiotic, antimycotic. Triplicate wells were assigned to
each time points for each virus strain.
The supernatants were collected at 0 h (following addition of the virus for a baseline and
a recovery back titer), 18 h, 24 h and 48 h post infection. Each supernatant was submitted
for virus titration on susceptible BT cells. The virus titer was calculated based on the
presence of CPE in case of BHV-1 and Cp strains of BVDV, or the intracytoplasmic
FITC staining in case of Ncp BVDV, according to (Reed and Muench, 1938).
Quantifying type I IFN
RT-qPCR was done according to the method described by (Rajput, 2013) with
modifications. Briefly, confluent primary tracheal cell or bovine turbinate cell line was
infected with 300 TCID50 of different strains of BRD related strains under investigation
for 18 hours at 37˚C. The cells were harvested 18 h pi and washed twice with PBS. RNA
was extracted from each sample using RNeasy extraction kit (Qiagen, Valencia, CA,
USA). RNase, DNase free water (Thermo Fisher Scientific, PA, USA) was used as a
negative extraction control. The extracted NA of different samples was normalized to 5
ng/µl using Nanodrop ND1000 (Fisher Scientific, NH, USA). Around 2 µl of the
normalized NA was used to start relative quantification of Type I IFN ; IFN-alpha and
beta in triplicates for each animal used in this study by using quantitative reverse
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transcriptase PCR (qRT-PCR). Triplicates of each treatment extracted nucleic acid were
submitted to run the qPCR in triplicates. qRT-PCR was done in 12.5 µl reaction using
Power SYBR® Green RNA-to-Ct™ 1-Step Kit (Thermo Fisher Scientific, PA, USA).
The quantification of cellular mRNA was done using an ABI 7900HT High-Throughput
Real-Time Thermocycler (Applied Biosystems, Life Technologies, Thermo Fisher
Scientific, PA, USA). The relative expression of mRNA was standardized using beta
actin as a housekeeping gene to ensure the PCR efficiency via stable expression of the
gene. Nucleic acid was extracted from mock-infected primary cells or cell lines and used
as a negative control. Nucleic acid was also extracted from primary cells or cell lines
treated with 2ug/mL LPS (Sigma-Aldrich, St. Louis, MO, USA) was used as a positive
control. LPS is a well-known inducer for IFN-type I. The cytokine primers used were
described by (Sobraske, 2018) Each qPCR experiment was followed by heat dissociation
curve step to verify the result and to exclude nonspecific amplification. qRT-PCR results
were analyzed using relative expression software tool (REST©2009 software) (Pfaffl et
al., 2002).
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RESULTS
Tropism of Bosavirus in different tissues of the American bison
The presence and levels of Bosavirus was evaluated in 7-9 different tissues of 4
American bison by qPCR. Out of the 4 animals, only 2 came back with positive levels of
viral DN. One of these 2 animals was BVDV-free (#18472) while the other was BVDVinfected (#18475). The Bosa viral copy number was at least one log higher in BVDV-free
animal compared to the BVDV-infected animal. In the case of BVD-free animal, the
spleen was the tissue that had the highest viral copies followed by the small intestine,
heart, and lung. In the case of the BVDV-infected animal, the spleen sample was
missing, and the highest copy number was found in small intestine followed by the heart,
lung and kidney. The viral copies were also detectable in lymph nodes and skin with low
copy number in these tissues (2 log 10) (Figure 3.2.).
Trophism and growth of BVDV in different tissues of the American bison
The presence and levels of BVDV was evaluated in 7-9 different tissues from
different 4 American bison from the same ranch by RT-qPCR. Out of the 4 animals, only
2 had positive levels of viral RNA. One of these 2 BVDV PI animals was Bosavirus free (#18474) while the other was Bosavirus-infected (#18475). Tissues from the
Bosavirus-free animal showed higher level of BVDV (3-4 log 10), , compared to the
Bosavirus-infected (2-3 log 10) in almost all tissues (Figure 3.2). BVDV was detectable
in the skin sample of both animals with 3 log 10 TCID50 equivalent/mL. The small
intestine and the heart had the lowest BVDV titers in both animals (2 log 10). Liver had
almost one log higher BVDV titer in the Bosavirus-infected animal than the Bosavirusfree BVDV animal (Figure 3.3).
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Susceptibility of primary bovine tracheal cell to BRD-related viral pathogen
Primary bovine tracheal cells were examined for their susceptibility to 4 viral
strains associated with BRD. The primary cells were infected with 300 TCID50 of Cp
Cooper strain of BHV-I, Cp singer strain of BVDV-I, Cp A125 strain of BVDV-II, or
Ncp 1373 strain of BVDV-II. BHV-1- specific CPE was detected as early as 36 h pi
(Figure 3.5.-C). The CPE specific for BVDV-I and II was not detectable until the end of
the 3rd day post-infection (Figure 3.5.-B & D). Intracytoplasmic FITC signal that
indicates Ncp BVDV replication was detectable 3 days pi (Figure 3.5.-E). The mockinfected cells had no CPE (Figure 3.5.-A).
Virus growth kinetics
The virus growth kinetics of primary bovine tracheal cells was compared to
susceptible bovine turbinate cell-line (BT). Infectious BHV-1 virus was produced by
either of the two infected cells (the primary and the cell line) as early as 18 h pi with
3.7E+03 virus titer/mL that continued to increase, reaching 1.8 and 7.4E+04 TCID50/mL
at 24 and 48 h pi respectively in the primary tracheal cells. The BT cell line produced a
slightly higher titer of 9E+03 at 18 h pi that continued to increase until reached 2.4 and
8.2 E+04 TCID50/mL at 24 and 48 h pi respectively (Figure 3.6.-A). Either the primary
or the cell line infected with Cp BVDV also produced infectious virus at 18 h pi that was
approximatley 7.7E+02 and 8.58E+02 TCID50/mL in the primary and cell line
respectively. The infectious Cp BVDV titer continued to increase until reaching 1.1E+04
and 1.35E+04 at 48 h pi in primary and cell line respectively with little differences
between the 2 cells and between the 2 genotypes BVDV-I Singer and BVDV II A125
(Figure 3.6.-C & D). Ncp 1373 produced an infectious virus titer of 9.3E+02 and
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1.2E+03 in the infected primary and cell line respectively at 18hr. This infectious titer
continued to increase to 1.00E+04 and almost 2.00E+04 at 48 h pi in the infected primary
and cell line respectively (Figure 3.6.-B). There was significantly more virus produced by
the BT cells versus the primary cells at 48hr (p<0.05).
Levels of type-I IFN in the infected primary cells
The level of IFN-alpha and beta were measured in both the primary tracheal cell
and BT cell line in response to various BRD-related viral infections. the measurement
was carried out on the mRNA level by a mean of RT-qPCR assay 18 h post infection.
The infection of either the primary cells or the cell line with 3 Cp BRD-viruses led to 46-fold increase in the transcriptional level of IFN-alpha while the infection of these cells
with the Ncp strain in vitro didn't affect IFN-alpha expression compared to the mockinfected cell (1.1-1.4-fold change) (Figure 3.7.-A). Similarly, the levels of IFN-beta
mRNA went up (3.3-4.7-fold increase) in all 3 Cp BRD viruses, compared to infection
with the Ncp strain and the mock treated control, where the expression changed 1.3-1.4fold (Figure 3.7.-B).
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DISCUSSION
This study demonstrated the trophism and growth of BVDV and Bosavirus in
different tissues of the American bison. It also demonstrated how co-infection of the 2
viruses in one animal may interfere with the virus replication of each other, compared to
singly infected animal with either strain. Our data showed by qPCR detection the infected
animals are most likely PI animal. This further confirms the ADRDL finding of BVDV
nucleic acid in the same two animals in samples collected more than fifty days apart
(Hause et al., 2021). Upon sequencing of the BVDV that was found in the American
bison, it was found that that the virus is 92% identical and closely related to Cp Oregon
strain of BVDV, which has been used in BVDV vaccines in the US. Another possible
implication is the spread of BVDV vaccine strain to the bison from a nearby cattle herd
that was vaccinated with the same strain (Hause et al., 2021; Byers et al., 2010). The
biotype of the bison strain was Ncp while the Oregon strain is Cp but there is evidence
although rare, of Cp viruses mutating and becoming Ncp.
Our BVDVPI bison data was compared to that of PI cattle in a previous study
conducted by Bhudevi and Weinstock, 2003. The comparison is shown in (Figure 3.4.).
The second half of this chapter measured the susceptibility of primary bovine
tracheal epithelial cells to BRD-related viral pathogen. BRD (Bovine respiratory disease)
is one of the most significant illnesses in cattle industry with huge economic losses
annually (Ridpath et al., 2006 & 2012). BRD is considered the most devastating disease
among cattle population. BRD has both viral and bacterial causative agents. Of the BRD
viral pathogens, we tested 3 different viruses: BHV-I, BVDV-I and BVDV-II. Our data
showed the susceptibility of primary bovine tracheal cells to all 3 pathogens with an
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ability of producing an infectious virus titer. The virus production was examined as early
as 18h post infection. The growth kinetics of the viruses in susceptible primary tracheal
cell was evaluated in comparison to a reference BT cell line. Previous research using the
same primary tracheal cells showed the susceptibility of these cells to influenza D virus
(Uprety et al.,2021). This increased the scope and importance of these cells to be used as
a candidate model for different bovine viruses.
Our data showed no significant difference between the two cell systems in the
replication and growth kinetics of the Cp viral pathogens: Cooper strain of BHV-1,
Singer strain of BVDV-I and A125 strain of BVDV-II; the progeny virus was being
produced at first sampling at 18h pi and continued to increase in virus titer by 1-2 logs at
24 and 48 h pi respectively. A similar pattern of growth curve was achieved by Sobraske,
2018 for BHV-1 on MDBK cells. On the other hand, testing the virus growth kinetics for
Ncp 1373 strain of BVDVII showed a significant difference at the last time 48 pi, where
there was at least one log higher level in the BT cells. The reason for that could be that
both cell types were infected when they reached 70% confluency and since the virus
maintenance medium containing 2% FBS, the BT cells may have continued to grow until
fully confluent. The faster-growing nature of BT cell line may allow it to reach 100%
confluency by the 48h time point, providing more cells to be infected and resulting in a
higher titer. Based on previous observations in vitro, the BT cell line is more susceptible
to BVDV than any other cell line. The susceptibility of cells to BHV-I or BVDV-I and II
requires the cells to have the specific receptors; glycoprotein D receptor (known as
nectin-1) and CD46 respectively. These receptors are present on the surface of all
epithelial cells (Dummer et al., 2014; Maurer et al., 2004). Since bovine tracheal cells are
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epithelial cells, these tracheal cells were susceptible to infection with BHV-1 was and
BVDV.
Type-I IFN transcriptional profile of primary bovine tracheal cells was evaluated
in response to infection with the 4 different strains of BDR-related pathogens. Our results
showed that IFN alpha and beta were up-regulated significantly in the primary tracheal
cell infected with either one of the 3 Cp strains; Cooper, singer or A125, compared to the
mock-treated cells. This response was insignificance from that one achieved in BT cellline. Our data was consistent with previously reported results (Abbas et al., 1996;
O'Garra, 1998; Kalinski et al., 1999; Sobraske, 2018; Trinchieri, 1995); whereas type I
IFN has been upregulated 12 h pi with Cp BVDV and BHV-I. Unlike the Cp strains,
different responses were recorded for Ncp 1373 strain of BVDV-II. Ncp BVDV did not
affect the expression IFN alpha or beta 18 h post infection in either primary tracheal cell
or BT cell line. Previous studies showed similar result of Ncp BVDV blocking IFN
production in infected somatic cells. Blocking of IFN response upon infection, allow Ncp
BVDV to infect and spread in a larger scale than the Cp and this may explain why most
of the BVDV field isolates are Ncp (Ridpath et al., 2006) Some researchers have even
suggested the importance of such mechanism in establishing the persistent infected
animal as IFN release is important both for innate protection and activation of the
adaptive immune response (Peterhans et al., 2003).
In conclusion, our data showed the trophism and levels of BVDV and Bosavirus
in different tissues of American bison. Our data confirmed that the BVDV-infected bison
were most likely to PI. Also, it suggested that the presence of bison near cattle is one of
the main factors to spread the infection in bison population. Our data also established that
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primary bovine tracheal cells are susceptible to infection by 4 BRD-related viruses. This
will give us advantage of studying in an in vitro experiment in cells that will represent the
cell type infected in vivo infected cells with BRD-related pathogen, as primary cell is
biologically relevant than cell-line. These cells should be reliable for viral studies,
however further work and characterization need to be done in future studies.
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Figure 3.1. Standard curves for Bosavirus nucleic acid template (A) and BVDV (B).
Bosavirus included standard concentrations that ranged from 1-200 ng/ul. In case of
BVDV, the stock concentration was at 1.5 E+6 TCID50/mL and it was diluted in 1 10fold manner till 1.5E+00. The PCR efficiency was> 86% and the R2 >0.996.
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Figure 3.2. The trophism of Bosavirus in different tissues of infected American bison
1 g of each tissue was used for nucleic acid extraction, the DNA content was measured
by nanodrop and normalized to 5ng/ul. The Bosavirus-specific DNA in normalized
samples was quantified by qPCR and the CT values of each tissue was plot against
standard curve to retrieve the corresponding DNA copy number in each sample. A:
Animal # 18472 (BVDV-free animal), B: Animal # 18475 (BVDV-infected animal). n=1
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Figure 3.3. The trophism of BVDV in different tissues of the American bison
A: Animal # 18474 (Bosavirus-free animal), B: Animal # 18475 (Bosavirus-infected
animal).
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Figure 3.4. Comparison between the trophism of BVDV in American bison and
domesticated cattle. * indicates significance (p<0.05). n=2
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A
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Figure 3.5. Susceptibility of bovine primary tracheal cells to BRD-associated viral
pathogens (BHV-I and BVDV). A) Mock-infected cells (cells+ VMM): showing normal
cell monolayer confluency, B) Cp Singer (BVDV-I)-infected cells: showing cells that
start to detach from the surface and some cell lysis, C) Cooper (BHV-1)-infected cells:
showing rounded cells with complete destruction of the monolayer, D) Cp A125 (BVDVII)-infected cells: showing lysed and detached cells , and E) Ncp 1373 (BVDV-II)infected cells showing intracytoplasmic fluorescent signal indicating viral replication in
the infected cells.
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Figure 3.6. Virus growth kinetics: The virus titer was measured in the supernatant of the
infected primary culture in contrast to the bovine turbinate cell line using endpoint
TCID50 assay on susceptible BT cells A) BHV-I; Cooper strain, B) BVDV-II; 1373
strain, C) BVDV-1; Singer strain, and D) BVDV-II; A125 strain. *: indicates significance
(p<0.05)
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Figure 3.7. Type-I IFN response in bovine primary tracheal cells in response to infection
with BRD-associated viral pathogens: The m RNA expression was measured in the
infected cells and compared to mock infected control (Cells and medium) by RT-qPCR.
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Figure 3.8. The mechanism of BVDV PI animal
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Hause et al., 2021
Figure 3.9. Phylogenetic analysis of bison Bosavirus genome.

125

Table 3.1. American bison submitted to the ADRDL for unthriftiness
ADRDL #

18472

18473

18474

18475

Animal

20-month-old

10-month-old

34-month-old

20-month-old

description

male

female

female

female

Tissue

Lung, Heart,

Lung, Heart,

Lung, Heart,

Lung, Heart,

submitted

Thymus,

Lymph node,

Lymph node,

Lymph node,

Lymph node,

Kidney,

Kidney,

Kidney, Small

Kidney,

Spleen, Small

Spleen, Small

intestine, Skin

Spleen, Small

intestine, Skin

intestine, Skin

and Liver

intestine and

and Liver

and Liver

Skin

Table 3.2. Primers and probe sequence used for detection of BVDV viral RNA

Item (BVDV)

Sequence

Forward Primer

5′-GGGNAGTCGTCARTGGTTCG-3′

Reverse Primer

5′-TGCCATGTACAGCAGAGWTTTT-3′

Probe

5′ -FAM− CCAGGTAAAAGCAGTTCT-3′ Iowa Black
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Table 3.3. Primers and probe sequence used for detection of Bosavirus viral DNA

Item (Bosavirus)

Sequence

Forward Primer

5′ -CAACCAGACACAGATACCGATAC-3’

Reverse Primer

5′ -CTGTCCCATACCTAAGATCGTG-3’

Probe

5′ -FAM− CCAGATTTCCCGGCCCCACATA-3′ Iowa Black

DNA template

5’-AACCAGACACAGATACCGATACCGGTGGCCTTACCTACCCA
GGAACCAGATATGTGGGGCCGGGAAATCTGGTACCGGCTGGC
CCTCCTGTTAATCCTATTGACGACCTGGCTCTGCAACACGATCT
TAGGTATGGGACAG-3’
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CHAPTER 4
GENERAL DISCUSSION
Bovine viral diarrhea virus (BVDV) is an endemic viral disease of cattle in the US
(Peterhans et al., 2010; Qi et al., 2019). While cattle are the main reservoir, BVDV can
infect a wide range of other animals (Nelson et al., 2016; Wolff et al., 2016; Van Campen
and Rhyan, 2010), and can invade and replicate in many tissues due to the bioavailability
of its receptors in almost all somatic cells in the body, this makes BVDV a pantropic
virus (Fassbender, 2007). BVDV is known for its immune-suppressive effect on the
infected animal (Hafez, 1975; Ridpath et al., 2006; Merwaiss et al., 2019), and for its
ability to persistently infect bovine species, creating a PI animal (Hause et al., 2021:
Nelson et al., 2016; Peterhans et al., 2003; Ridpath et al., 2013). Immune suppression is
usually associated in the field with lymphoid depletion in the infected animal (Ammari et
al., 2012; Falkenberg et al., 2014; Liebler-Tenorio et al., 2003), and usually followed by a
secondary bacterial infection (Ackermann et al., 2010; Ridpath et al., 2006). while PI
animal is the main source of infection (Chase et al., 2004; Stahl and Alenius, 2012) that
continue to spread the infection on the farm. All these factors support BVDV infection to
negatively impact animal production and reproduction (Arnaiz et al., 2021, Ridpath et al.,
2006), and causes severe economic losses annually (Houe, 2003), despite the current
vaccine strategy, which also has other implications and doubts (Fulton et al., 2002; Stahl
and Alenius, 2012).
The first half of this work aimed to study the immune dysfunction impact of
BVDV on the infected animal in vitro. Based on previous literature and preliminary data
in our lab, we developed our hypothesis, which is centered around the key role of
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macrophages in BVDV pathogenesis. Our hypothesis was that "BVDV-infected MDM
release factors that induce lymphocyte apoptosis and affect neutrophil viability, and
functional activity, favoring the secondary bacterial infection that is associated with
BVDV cases in the field". We have already proven the lymphocyte apoptotic effect of the
infected MDM in a previous study. In the current work, we extended our investigation to
include studying the effect of the infected MDM on neutrophil viability and functional
activity, and we are still looking to reveal the identity of these factors that triggered
lymphocyte apoptosis.
The hypothesis of this immune-dysfunction related work was examined using the
following objectives:
1. To identify the soluble factors of the infected macrophage that induce
lymphocyte apoptosis.
2. To examine the impact of these soluble factors on neutrophil viability,
surface marker expression, and functional activity of neutrophils to
investigate a possible immune cell interaction in response to BVDV
infection.
To achieve the first objective, we used the following approaches:
a) Studying the role of the soluble viral proteins in the infected MDM
supernatant in inducting lymphocyte apoptosis by depletion using immune
precipitation.
b) Studying the role of apoptosis-related cytokines in the infected MDM
supernatant in inducing lymphocyte apoptosis by protein level analysis.
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c) Studying the difference between the protein content of infected, and
mock-infected MDM by Mass spec.
To achieve the second objective, we used the following approaches:
a) Studying the effect of infected MDM supernatant on neutrophil's viability
by colorimetric-based assay.
b) Studying the effect of infected MDM supernatant on neutrophil surface
marker expression by flow analysis.
c) Studying the effect of infected MDM supernatant on neutrophil's
functional activity by a combination of colorimetric-based assay and flow
analysis.
This study demonstrated the key role of macrophages in BVDV pathogenesis in
vitro. it helped suggest the immune dysfunction state associated with BVDV infection
and attributed it to the lymphocyte apoptosis and compromised neutrophil functional
activity, that was induced by infected MDM supernatants. In this study, the effect of
BVDV-infected MDM supernatants on neutrophil viability, surface marker expression,
and functional activity was evaluated. None of the infected MDM supernatants had a
significant effect on neutrophil viability up to 6 h post-treatment compared to the mocktreated control. Our findings were inconsistent with the findings reported of Thakur 2017,
as neither the TGAN (Ncp) nor TGAC (Cp) strain of BVDV affects the neutrophil
viability. Other studies reported observable neutropenia or had impaired neutrophil
activity in vivo following BVDV infection (Brown et al., 1991; Roth et al., 1981).
However, this finding has been reported in vivo, which is quite a different environment
than in vitro. This result could be due to a direct effect on hematopoietic production, it
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could also be due to cell margination or other hemodynamic mechanisms that may affect
the neutrophil levels in the blood.
This study showed that the infected MDM supernatants downregulated the
expression of CD18 compared to the mock-treated control, however, the difference was
not significant (p =0.088). All the supernatants significantly down-regulated L-selectin
expression on the surface of neutrophils compared to the mock-treated control at 6 h posttreatment (p< 0.05). CD18 and L- selectin are 2 important surface markers that regulate
neutrophil adhesion, rolling, diapedesis, and signal trafficking to the site of local injury.
Impairment of their expression will affect the net functional activity of neutrophils
(Walzog et al., 1999, Kolaczkowska and Kubes, 2013). CD18 is important for the
maturation and release of neutrophils to the circulation in vivo, while L-selectin help in
margination and receptor-mediated homing (Gomez and Doerschuk, 2010). This
suggested that the downregulation of CD18 and L-selectin in vivo can lead to neutropenia
(Yoshitake et al., 2002), and this may explain the findings of Roth et al., 1981. In
previous work, both L-selectin and CD18 were downregulated in response to direct
infection of neutrophils with BVDV strains, which was linked with a significant negative
impact on normal neutrophil functional activity, especially migration (Thakur et al.,
2020; Al-Kubati et al., 2021). Additionally, CD14 expression was also evaluated in the
current study. However, its expression was low on the mock-treated neutrophil (< 13% at
0 h) and none of the treatments significantly changed this percentage at 6 h posttreatment. CD14 is an endotoxin receptor, so it aids in the recognition of invading gramnegative bacteria as well as its role with TLR-4 in phagocytosis. The highly virulent 1373
MDM supernatant significantly downregulated the expression of CD14 but not the low
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virulent 28058 MDM supernatant as early as 12 h post-treatment. CD14 downregulation
was associated with the reduction in the phagocytic activity of macrophage in the same
study (Abdelsalam et al., 2020) and of neutrophils in hepatitis C virus (HCV) patients
(Jirillo et al., 1995).
The functional activity of neutrophils in response to different BVDV-infected
MDM supernatants has been evaluated. Phagocytosis is one of many defense mechanisms
that is used by phagocytes to defend against microbial invasion. Phagocytosis is
considered a link between innate and adaptive immune response as successful phagocytic
activity leads to successful antigen presentation and thus good initiation of the adaptive
immune response. In this study, none of the MDM supernatants affected the phagocytic
activity of neutrophils at 6 h post-treatment compared to the mock-treated control
(p=0.14). A previous study reported that neutrophils isolated from Cp BVDV-infected
animals showed a decrease in paraffin oil uptake in contrast to neutrophils isolated from
noninfected control (Roth et al., 1981). Abdelsalam et al., 2020 has reported the effect of
BVDV-infected MDM supernatants on macrophage phagocytic activity compared to the
direct BVDV infection of macrophages. Only virulent BVDV or its corresponding
infected MDM supernatant significantly inhibited the phagocytic activity of treated
MDM compared to the mock-treated control. This inhibitory effect was as early as 12h
post-infection with virulent 1373 strain and at 24 h post-treatment with 1373-MDM
supernatant. Because of the short half-life of neutrophils, our assay was at 6 h posttreatment which could be too early for the MDM supernatant to show their effect.
Previous research has shown that Cp BVDV strains were able to reduce neutrophil
phagocytic activity (Thakur et al., 2020; Al-Kubati et al., 2021). The difference could be
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either due to the use of different strains as in (Al-Kubati et al., 2021) or the fact that our
finding is based on the effect of infected MDM supernatant rather than direct infection
with the virus.
Our study also measured the oxidative burst activity of neutrophils in response to
different BVDV-infected MDM supernatant at 6 h post-treatment. All infected MDM
supernatants reduced the oxidative burst activity of PMA-stimulated neutrophils
compared to the mock-treated PMA-stimulated control (p> 0.05). Our results showed that
the greatest downregulation occurred following treatment with Cp 296c MDM
supernatant with a 7.2% decrease compared to the mock-treated control. A previous study
showed the oxidative burst activity in response to BVDV direct infection of neutrophils
was downregulated in response to the 4 strains of BVDV, regardless of their virulence or
biotype at 6 h post-infection (Thakur, 2017). The difference between this finding and
ours could be because we tested the infected MDM supernatant rather than directly
infecting neutrophils with BVDV strains. Inhibition of neutrophil functional activity
following BVDV infection has also been reported in other studies that have been
conducted on neutrophils isolated from vaccinated animals with modified live singer Cp
BVDV strain (Roth and Kaeberle, 1983).
The nitric oxide production of LPS-stimulated neutrophils has been evaluated in
response to different BVDV-infected MDM supernatants at 6h post-treatment compared
to the mock-treated group. Only Cp BVDV supernatant significantly reduced nitric oxide
production in the stimulated neutrophils. Cp 296c supernatant showed more than 37%
reduction in nitric oxide production from the mock-treated control compared to less than
7% in the Ncp supernatants. ROS and NO production are the 2 major mechanisms by
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which the phagocytosed pathogen will be destroyed. Our data concurred with Elmowalid,
2003 where only supernatant from MDM infected with Cp strain up-regulated NO
production in the LPS-stimulated MDM. Our data also concurred with previous work
(Abdelsalam et al., 2020) that the NCP MDM supernatant didn't significantly affect NO
production compared to mock-LPS stimulated control at 12-24h post-treatment. Other
studies showed that infection with HCV, another flavivirus, upregulated NO production
in mice livers (Lasarte et al., 2003).
This study also tested the ability of PMA-stimulated neutrophils to undergo NET
formation in response to treatment with different BVDV-infected MDM supernatants at
6h post-treatment compared to the mock-treated-PMA stimulated control. Only Cp
MDM supernatant significantly downregulated NET formation by 18.6% (p < 0.05)
compared to the mock-treated PMA stimulated control. On the other hand, less than 3%
inhibition was reported in the case of Ncp MDM supernatants. Thakur et al., 2020
showed that the infection of neutrophils with BVDV led to significant up-regulation in
NET formation, regardless of their virulence or biotypes. The difference between this
finding and ours could be due to several reasons. These reasons include but are not
limited to, the different design of the experiment where we examine the effect of the
infected MDM supernatants rather than BVDV direct infection of neutrophils. Another
difference could be the way that we measure the NET formation is based on the detection
of the extracellular DNA while in the other research, they examined the presence of
extracellular elastases. Also, the original hypothesis and method of analysis as we
examined the impact of the infected supernatants on the NET formation from the PMAstimulated neutrophils while in the case of Thakur et al., they examined the ability of
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BVDV infection of neutrophil in inducing NET formation and they only used PMA as a
positive control.
In a previous study conducted in our lab, we reported that the high virulent
BVDV-infected MDM supernatant was able to induce lymphocyte apoptosis in vitro as
early as 24h post-treatment. The mechanism by which this supernatant exerts lymphocyte
apoptosis is not characterized (Abdelsalam et al., 2020). Previous studies reported the
involvement of different factors and mediators, of viral and cellular origin, in the
pathogenesis and outcome of BVDV (Janeway et al., 2001; Jensen et al., 1991; Darweesh
et al., 2018 Markham et al., 1985; Van Reeth et al., 1997; Welsh et al., 1995).
In the current study, we have tried to investigate the content of these apoptotic
supernatants. Previous work suggested the involvement of Erns glycoprotein as a soluble
factor that can induce lymphocyte apoptosis in CSFV (Bruschke et al., 1997) We have
tried to exclude the possible role of soluble viral proteins in the supernatant that initiate
lymphocyte apoptosis. We have depleted viral factors by immune-precipitated from the
apoptotic supernatant, and we re-tested the lymphocyte apoptosis. Our data suggested
ruling out the role of soluble viral proteins in inducing lymphocyte apoptosis. Next, we
sought to examine the other cellular factors that may be present in the apoptotic
supernatant by examining the content of two possible apoptosis-related cytokines. We
were not able to detect the presence of either TNF-alpha not IL-1 beta in the apoptotic
supernatants although we used a highly sensitive ELISA detection kit (pg/ml level). That
may suggest the that these two cytokines are not responsible for the induction of
lymphocyte apoptosis. Our findings were different from those reported in the case of
CSFV where TNF-alpha was involved in the process of triggering lymphocyte apoptosis
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(Choi et al., 2004). The work of Choi with CSFV was based on immunohistochemistry
and has not been repeated. However, our work data was consistent with a previous work
that excluded the role of pro-inflammatory cytokines in the induction of lymphocyte
apoptosis in vitro (Pedrera et al., 2009).
In conclusion, our data supported the important role of macrophages as a key
component in the pathogenesis and outcomes of BVDV infection. Our results help
explain the immune dysfunction that is associated with BVDV infection and seen as
lymphoid depletion and secondary bacterial infection in the field. These findings suggest
that the Cp BVDV biotype which is present in most of the commercially available
vaccines in the US may impact the innate immune defense and neutrophil health of the
vaccinated animal (Figure 4.1). This is supported by field observations that in the face of
multiple stressors delaying the use of BVDV containing MLV reduces mortality and
retreatments. Further future studies need to be conducted to identify the nature of these
soluble factors and the mechanism by which they induced lymphocyte apoptosis.
Running mass spectrometry on the virulent supernatant compared to the non-virulent one
may suggest certain candidate factors that can be further ruled out or confirmed by target
specific testing of each candidate via ELISA, western blot or similar testing as needed.
The other part of the dissertation included both an in vivo study and an in vitro
study. The in vivo study observed the tropism and co-infection of BVDV and Bosavirus
in different tissues of the American bison. The BVDV RNA was isolated from all tissues
in the BVDV-infected animals that were tested, including the ear notch samples. This
suggested that the infected animals are most likely PI animal. These findings were
consistence with the findings of the ADRDL for the same animals where the RNA was
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detected in serum and nasal secretions collected more than fifty days apart (Hause et al.,
2021). The co-infection of bison with BVDV and Bosavirus ended up with lower virus
replication for both viruses in different tissues. This agrees with what has been found
upon testing the viral nucleic acid for both viruses in singly vs co-infected animals in
nasal and serum sample (Hause et al., 2021). Our data suggested a PI bison with higher
viral load in internal organ than in skin sample. This was different from previously
reported in case of cattle persistently infected with BVDV (Bhudevi and Weinstock,
2003). This may affect the feasibility of detecting PI animals in cattle than in bison, since
most of the diagnostics depends on the ear notch-skin sample.
The in vitro study focused on comparing the response and susceptibility of a
primary bovine tracheal cells and the established BT cell line to BRD-related viral
pathogen. Our data showed the susceptibility of primary bovine tracheal cells to BVDV
and BHV-1 with a growth kinetics similar to that of the established BT cells. Previous
research using the same primary tracheal cells showed the susceptibility of these cells to
influenza D virus (Uprety et al.,2021). This increased the scope and importance of these
cells to be used as a candidate model for different bovine viruses. Additionally, we
showed no significant difference between the primary and the established BT cell line in
their IFN-I response to infection with Cp or Ncp viruses. Our data was consistent with
previously reported results (Abbas et al., 1996; Kalinski et al., 1999; O'Garra, 1998;
Ridpath et al., 2006; Sobraske, 2018; Trinchieri, 1995); whereas type I IFN has been
upregulated 12 h pi with Cp BVDV and BHV-I, but not the Ncp BVDV in either primary
tracheal cell or BT cell line. These cells should be reliable for viral studies, however
further work and characterization need to be done in future studies.
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Figure 4.1. Take-home message: Schematic diagram showing our
hypothesis and the key role of macrophages in the immune-dysfunction role
of BVDV in infected animals.

